A driven team dedicated to providing support and opportunities needed for startups to prosper and pioneer the future of technology

People

The EvoNexus Team, Board of Directors, Mentors and Selection Committee are comprised of deeply experienced, industry-expert volunteers representing the most influential technology companies in the world, such as Qualcomm, ViaSat, and more. These individuals assist in selecting and mentoring ventures admitted to the incubation program.

Rory Moore

Rory Moore

EvoNexus CEO & Co-Founder, Founder, Peregrine Semiconductor Corp. & Silicon Wave, Inc.
Vice Admiral Walter Davis

Vice Admiral Walter Davis

EvoNexus Co-Founder & VP Organizational Dev., Former Navy N6, Dir. Space Systems, Information Warfare Systems, Command & Control Systems
Gene Dantsker, Ph.D., MBA

Gene Dantsker, Ph.D., MBA

EvoNexus Executive Advisor, Former Sr. Director of Business Development & Licensing, Qualcomm
Rich Stewart

Rich Stewart

EvoNexus Executive Advisor & 5G Portfolio Director, Former Senior Director, Qualcomm
Ron Melanson

Ron Melanson

EvoNexus Silicon Valley Chief Engineer & Operations, Former VP Hardware Engineering, Sun Microsystems & Oracle
Bridget Kimball

Bridget Kimball

EvoNexus Executive in Residence, Former VP Engineering & Chief Architect, Consumer Group, Intuit
Hem Suri

Hem Suri

EvoNexus Fintech Executive In Residence, Founder & Managing Partner, Spark Growth Ventures
Sumit Tomar

Sumit Tomar

EvoNexus Executive in Residence, CEO, Adura LED Solutions
Ashlyn Haines

Ashlyn Haines

EvoNexus Portfolio & Events Manager and Board Liaison

Rory Moore

EvoNexus CEO & Co-Founder, Founder, Peregrine Semiconductor Corp. & Silicon Wave, Inc.

EvoNexus CEO & Co-Founder / Founder, Peregrine Semiconductor Corp. & Silicon Wave, Inc.

Rory Moore was the seed round investor, co-founder of Peregrine Semiconductor Corp. (NASDAQ: PSMI), now a Murata Company, one of the world’s leading providers of radio frequency integrated circuits (RFICs) for the wireless communications and aerospace markets. Rory was also the seed round investor and founding CEO of Silicon Wave, Inc., now owned by Qualcomm. Silicon Wave produced the world’s first Bluetooth chips. In 2009 Rory founded a technology incubator called EvoNexus with Vice Admiral Walter Davis, a board member of EvoNexus. A University of Michigan graduate, Rory continues to make angel investments in technology firms throughout the region. His other passions include Unlimited Aerobatic Competition flying, scuba diving and surfing.

Vice Admiral Walter Davis

EvoNexus Co-Founder & VP Organizational Dev., Former Navy N6, Dir. Space Systems, Information Warfare Systems, Command & Control Systems

EvoNexus Co-Founder & VP Organizational Dev. / Former Navy N6, Dir. Space Systems, Information Warfare Systems, Command & Control Systems

Vice Admiral Walter J. Davis, USN (Ret) was Navy N6, Director Space systems, Information Warfare systems, Command and Control Systems, and Modeling and Simulation where he directed Navy’s $3.5B IT budget. He is former VP for Business Development at GDE Systems (BAE). He was a Navy fighter pilot, Aircraft Carrier CO, and Battle Group Commander. He served in numerous Navy engineering positions including Navy Engineer for the F-14 and Naval Warfare IT Architect (SPAWAR), He was a co-founder of E-fire. He is an Ohio State University Electrical Engineering graduate. 

Gene Dantsker, Ph.D., MBA

EvoNexus Executive Advisor, Former Sr. Director of Business Development & Licensing, Qualcomm

EvoNexus Executive Advisor

Dr. Gene Dantsker is the former President and Chief Operating Officer and current Executive Advisor of EvoNexus. He has been involved with EvoNexus since its founding as selection committee member, mentor to numerous portfolio companies, Executive-in-Residence and most recently Chief MedTech Officer. Gene is a seasoned entrepreneur, board member, advisor, operational executive and angel investor.

Prior to the EvoNexus role, Gene worked across the spectrum of technology solutions in semiconductor, IT, medical and biotech businesses. His career path brought together engineering, science, business and entrepreneurship.

Following graduate school, Gene was Senior Technical Staff Member at TRW, Inc., Space and Electronics Division (now part of Northrop Grumman) where he was responsible for design, fabrication, and integration of microelectronics for space/satellite applications. Subsequently he co-founded Nanostream, Inc., a biotechnology company and provider of high-throughput bio-analytical instruments to companies involved in drug discovery and development. As VP of Technology, Dr. Dantsker was co-inventor and developer of Nanostream’s core technologies based on polymer MEMS microfluidics and converted them into commercial products purchased by leading pharmaceutical companies. Gene then served as CEO and CTO of aDNAvance Technologies, Inc., a provider of ultra-sensitive medical molecular diagnostic products, operating out of the US and Canada. Gene also served on the Board of Directors of D-Wave Systems, a pioneer in Quantum Computing, with leading Silicon Valley VCs, as well as heavily consulted the company in business development, IP strategy, growth strategy and operational infrastructure. Gene subsequently headed business development for the US branch of Nitto Denko, a leading supplier of diversified polymer-film products for medical, electronic and optronic applications, based in Osaka, Japan.

Gene then joined Qualcomm Life as Sr. Director of Business Development & Licensing, where his responsibilities included enabling intelligent integrated care models through the Internet of Things (IoT) in the pharmaceutical, medical device, diagnostics and payer industries. In 2020, he helped sell the original Qualcomm Life business, to Philips before moving on. Following the sale, Gene joined Amazon Web Services as Global Lead for Medical Devices.

Gene holds B.S. degrees in Physics and Mathematics from the University of Maryland, M.A. and Ph.D. in Physics from the University of California at Berkeley, and an MBA from San Diego State University, where he was class valedictorian. He is an inventor on over 60 issued patents.

Rich Stewart

EvoNexus Executive Advisor & 5G Portfolio Director, Former Senior Director, Qualcomm

EvoNexus Executive Advisor & 5G Portfolio Director / Former Senior Director, Qualcomm

Rich Stewart is a System on a Chip (SoC) engineering subject matter expert with extensive experience in technical management, innovation, and product commercialization. Rich possesses a strong track record developing efficient, practical and cost-effective processes, in addition to a strong track record of on time product delivery. He successfully builds and integrates high-performance R&D teams, and effectively collaborates with multi-disciplinary, global, project teams to efficiently advance development programs.

Rich is a co-founder of Prometheus Technology Solutions, LLC, a firm dedicated to providing scalable product delivery processes for HW/SW/SOC and IoT products. Rich held multiple engineering leadership positions at Qualcomm, beginning in 1994, covering a broad cross section of technologies including embedded mobile device software, wireless protocols, image compression systems, MEMs driver technology, systems engineering and memory solutions. While at Qualcomm Rich also managed the Qualcomm Innovation Network, and was an engineering patent mentor. Prior to joining Qualcomm Rich developed driver level engineering solutions in imaging, 3d rendering and image scanning technologies at multiple start-ups.

Rich has over 25 issued and pending US patent applications, along with a multitude of international filings.

Rich has a B.S. in Mathematics-Computer Science, from the University of California, San Diego

Ron Melanson

EvoNexus Silicon Valley Chief Engineer & Operations, Former VP Hardware Engineering, Sun Microsystems & Oracle

EvoNexus Silicon Valley Chief Engineer & Operations / Former VP Hardware Engineering, Sun Microsystems & OracleRon Melanson serves as Chief Engineer & Operations for EvoNexus Silicon Valley. He previously served as Vice President of Engineering and managed the Hardware Quality Office at Oracle Corp.As VP of Engineering, he was responsible for Hardware Central Engineering, hardware quality, and customer advocacy. To this capacity, his organization provided customer solutions and best practice guides, competitive benchmarking, application tuning, and advanced compiles. His team also supported compliance, safety and RoHS testing, and certification.Prior to Oracle, Ron served a dual role at Sun MicroSystems as Distinguished Engineer and Vice President of Engineering. To that capacity, he managed the development of several SRARC CPU programs and lead the development of advanced semiconductor technologies with strategic FAB partners.Ron’s engineering career before Sun Microsystems was rooted at Digital Equipment Corporation, where Ron served as a consulting engineer developing process technologies, custom chips and EDA tools for the development of VAX and high end systems.Ron took his B.S. and M.S degrees in E.E. at Northeastern University.

Bridget Kimball

EvoNexus Executive in Residence, Former VP Engineering & Chief Architect, Consumer Group, Intuit

Executive in Residence, EvoNexus / Former VP Engineering & Chief Architect, Consumer Group, Intuit

Bridget was formerly VP Engineering, Fellow, and Chief Architect at Intuit’s Consumer Group, focusing on products for personal tax and finance management. Previous to Intuit, she was at Comcast and served as President of a joint venture developing next generation conditional access and security products for the cable industry. She has also held senior engineering roles at Motorola, Copper Mountain Networks, General Instrument and Hughes Space and Communications Group.

She has received numerous industry awards and recognition, including 2016 CableFax Most Powerful Women in Cable (Technology Award) in 2016, and has a strong commitment to mentoring the next generation of women in technology. She also has served on the United Way’s Women’s Leadership Council, was a past mentor for Athena, and volunteered as a troop leader and mentor for the Girl Scouts of America.

Bridget has an M.S. in Electrical Engineering from University of Southern California (USC) and a B.S. in Electrical and Computer Engineering from California State Polytechnic University. She has also completed the Executive Program for Scientists and Engineers (EPSE) at the University of California, San Diego, and an executive leadership program through the Center for Creative Leadership. She holds 5 US patents.

Hem Suri

EvoNexus Fintech Executive In Residence, Founder & Managing Partner, Spark Growth Ventures

Founder & Managing Partner, Spark Growth Ventures / EvoNexus Fintech Executive in Residence

Hem is an accomplished investment, board and executive management leader with two decades of experience as an entrepreneur, venture capitalist, board professional, investment banker, general management executive as well as a researcher.

Hem currently serves as the Founder & Managing Partner of Spark Growth Ventures, an early-stage technology venture capital firm with a Pan American focus. Previously, he was the Co-Founder and Managing Partner of ClearVision Equity, a 2x Interim CEO of emerging healthcare companies, an executive of a KKR Private Equity portfolio company, an investment banker on Wall Street as well as a functional leader in multiple Fortune 500 companies in the US.

Hem has also served on over 20 startup and social enterprise boards across US and is heavily involved with several prominent incubators and accelerators in SoCal supporting budding entrepreneurs. He has executed 40+ venture, private equity and M&A transactions with over $2B in total capital spanning over 12 years at Spark Growth Ventures, ClearVision Equity Partners, Deutsche Bank, and a KKR private equity portfolio company.

Hem has an M.B.A. from Harvard, an M.S. from University of Illinois and a B.Tech. from Indian Institute of Technology, New Delhi. He is passionate about the environment, equality and education for under-privileged children, and loves reading, traveling and active pursuits.

Sumit Tomar

EvoNexus Executive in Residence, CEO, Adura LED Solutions

EvoNexus Executive in Residence / CEO, Adura LED Solutions

Sumit Tomar currently serves as the CEO of Adura LED Solutions, wherein he is responsible for Adura LED design and manufacture LED modules, with best-in-class thermal management in the industry, enabled by it's patented SinkPAD™ technology. Adura's high performance LED Modules help designers with best in class heat dissipation, longer life and better overall Luminaire performance across different vertical markets including - industrial lighting, street lighting, automotive, high end consumer, horticulture & indoor farming.

Sumit Tomar previously served as the CEO of pSemi Corporation, a Murata subsidiary focused on RF, analog and mixed-signal ICs. Formerly Peregrine Semiconductor, pSemi has over 600 employees and eight offices worldwide.

Prior to joining pSemi in 2017, he held product line management positions at several prominent technology companies, including Qorvo, Texas Instruments and Skyworks Solutions Inc. He has a proven track record of managing design win strategies and driving rapid revenue growth at Tier-1 OEMs in smartphones, telecom infrastructure, industrial and automotive markets.

He received a Master of Science in electrical engineering from Indian Institute of Technology (IIT), Roorkee and completed the Executive Management Program at Stanford University.

Ashlyn Haines

EvoNexus Portfolio & Events Manager and Board Liaison

Portfolio & Events Manager and Board Liaison

 Ashlyn Haines is a recent California State University, San Marcos graduate with a Bachelor of Arts in Psychology. She continues to be passionate about the field of psychology and social sciences, and how these sciences are applicable to the real world. During her time at California State University, San Marcos she learned about the importance of psychology and understanding the human mind in the field of marketing and events planning. She has also been active in her community as a San Diego local and has worked closely with her local church as the lead coordinator of a leadership team. This as well as her education in psychology has ignited the passion for marketing and events planning as a career path. She is happy to be working as the Portfolio & Events Manager and Board Liaison for EvoNexus.

Rory Moore

Rory Moore

EvoNexus CEO & Co-Founder, Founder, Peregrine Semiconductor Corp. & Silicon Wave, Inc.
Vice Admiral Walter Davis

Vice Admiral Walter Davis

EvoNexus Co-Founder & VP Organizational Dev., Former Navy N6, Dir. Space Systems, Information Warfare Systems, Command & Control Systems
Richard Baldridge

Richard Baldridge

EvoNexus Chairman, Director, ViaSat Director
Tim Holl

Tim Holl

EvoNexus Treasurer, Partner, Ernst & Young
John Major

John Major

EvoNexus Chairman Emeritus, Former Chairman, Broadcom
Kathy Ouellette

Kathy Ouellette

EvoNexus Vice Chairman, CEO & President, Perma Pure
Steve Rowles

Steve Rowles

EvoNexus Secretary, Managing Partner, Morrison Foerster
Derek Aberle

Derek Aberle

Co-Founder & Executive Vice Chairman, VIREWIRX
Ziad Asghar

Ziad Asghar

SVP, Product Management - Snapdragon Technologies & Roadmap, Qualcomm
Alex Balazs

Alex Balazs

CTO, Intuit
Jordan Becker

Jordan Becker

VP & GM Geospatial Intelligence & ISR, BAE Systems
Joe Boerio

Joe Boerio

EVP, Chief Risk & Transformation Officer, Franklin Templeton Investments
William Eigner

William Eigner

Partner, Business/Technology Team, Procopio
Dana Escobar

Dana Escobar

CLO & GM, Semiconductor, Adeia
Burton Goldfield

Burton Goldfield

President & CEO, TriNet
Paul Hartke

Paul Hartke

Fellow, AMD
Dong-Su Kim, Ph.D.

Dong-Su Kim, Ph.D.

CEO & Board Member, Corporate EVP, LG Technology Ventures
Dr. Richard Kurtz

Dr. Richard Kurtz

VP Corporate Business Development, Bio-Rad
John Langan, PhD

John Langan, PhD

CTO, EMD Electronics
John “Rick” LeMoine, MD

John “Rick” LeMoine, MD

CMIO, Sharp HealthCare
Dr. Quinn Li

Dr. Quinn Li

SVP & Global Head, Qualcomm Ventures
David Marino

David Marino

Co-Founder & Senior EVP, Hughes Marino
Craig Miller

Craig Miller

President, Global Space Networks, Viasat
Bardia Moayedi

Bardia Moayedi

Partner, Snell & Wilmer
Zachary Myers

Zachary Myers

Partner, Wilson Sonsini Goodrich & Rosati
Rodd Novak

Rodd Novak

VP Corporate Planning & Development, pSemi
Carlos Nunez, M.D.

Carlos Nunez, M.D.

CMO, ResMed
Eddy Ortiz

Eddy Ortiz

VP of Innovation & Solution Acceleration, Royal Bank of Canada
Rajesh Pankaj, Ph.D.

Rajesh Pankaj, Ph.D.

EVP, CTO, InterDigital
Dr. Karthik Ranganthan

Dr. Karthik Ranganthan

WW VP, Alaris Business Leader, BD
Eric Reed

Eric Reed

SVP, Sales and Distribution, TriNet
Kenneth Rollins

Kenneth Rollins

Partner, Cooley LLP
Todd Stallard

Todd Stallard

GM US IoT, Sigma Connectivity
Mehul Udani

Mehul Udani

VP of Corporate Technology & Innovation, Murata Americas

Rory Moore

EvoNexus CEO & Co-Founder, Founder, Peregrine Semiconductor Corp. & Silicon Wave, Inc.

EvoNexus CEO & Co-Founder / Founder, Peregrine Semiconductor Corp. & Silicon Wave, Inc.

Rory Moore was the seed round investor, co-founder of Peregrine Semiconductor Corp. (NASDAQ: PSMI), now a Murata Company, one of the world’s leading providers of radio frequency integrated circuits (RFICs) for the wireless communications and aerospace markets. Rory was also the seed round investor and founding CEO of Silicon Wave, Inc., now owned by Qualcomm. Silicon Wave produced the world’s first Bluetooth chips. In 2009 Rory founded a technology incubator called EvoNexus with Vice Admiral Walter Davis, a board member of EvoNexus. A University of Michigan graduate, Rory continues to make angel investments in technology firms throughout the region. His other passions include Unlimited Aerobatic Competition flying, scuba diving and surfing.

Vice Admiral Walter Davis

EvoNexus Co-Founder & VP Organizational Dev., Former Navy N6, Dir. Space Systems, Information Warfare Systems, Command & Control Systems

EvoNexus Co-Founder & VP Organizational Dev. / Former Navy N6, Dir. Space Systems, Information Warfare Systems, Command & Control Systems

Vice Admiral Walter J. Davis, USN (Ret) was Navy N6, Director Space systems, Information Warfare systems, Command and Control Systems, and Modeling and Simulation where he directed Navy’s $3.5B IT budget. He is former VP for Business Development at GDE Systems (BAE). He was a Navy fighter pilot, Aircraft Carrier CO, and Battle Group Commander. He served in numerous Navy engineering positions including Navy Engineer for the F-14 and Naval Warfare IT Architect (SPAWAR), He was a co-founder of E-fire. He is an Ohio State University Electrical Engineering graduate. 

Richard Baldridge

EvoNexus Chairman, Director, ViaSat Director

EvoNexus Chairman / Director, ViaSat

Richard Baldridge has been a director of Viasat since 2016. Mr. Baldridge joined Viasat in 1999, serving as Executive Vice President, Chief Financial Officer and Chief Operating Officer from 2000, as Executive Vice President and Chief Operating Officer from 2002, and as President and Chief Operating Officer from 2003. Mr. Baldridge served as President and Chief Executive Officer from November 2020 through July 2022, and served as Vice Chairman from July 2022 until his retirement in June 2023. In addition, Mr. Baldridge serves as a director of Ducommun Incorporated (NYSE: DCO), a provider of engineering and manufacturing services to the aerospace and defense industries, and EvoNexus, a San Diego based non-profit technology incubator.

Mr. Baldridge came to ViaSat from Raytheon Corporation where he was vice president and general manager of its Raytheon Training Systems division. With over 4,000 employees in the division, his responsibilities included day-to-day management including marketing, legal, finance, and overall management. Other experience includes roles as chief operating officer, CFO, and VP of finance and administration for Hughes Information Systems and Hughes Training Inc., before the divisions were acquired by Raytheon in 1997. Mr. Baldridge also held various senior management roles within General Dynamics Corporation.

Mr. Baldridge graduated with a B.S. degree in business administration, and an emphasis in information systems from New Mexico State University, Las Cruces, where he is a member of the NMSU School of Business Hall of Fame. He serves as Chairman of the Board of Directors of EvoNexus.

Tim Holl

EvoNexus Treasurer, Partner, Ernst & Young

EvoNexus Treasurer / Partner, Ernst & Young

Tim Holl is currently a Partner in the San Diego office of Ernst & Young after transferring from the San Francisco office. Tim is focused on serving companies in the semiconductor, software and tele- communication industries. Tim is a leader in Ernst & Young’s education and audit methodology efforts as well. He is a Certified Public Accountant licensed to practice in California and a member of the AICPA. He graduated from the University of California, Santa Barbara, with a B.S. in business economics.

John Major

EvoNexus Chairman Emeritus, Former Chairman, Broadcom

EvoNexus Chairman Emeritus / Former Chairman, Broadcom

John Major is the Founder and President of MTSG, a strategic consulting business specializing in emerging opportunities. Previously, he was Chairman and CEO of Apacheta, a wireless applications company, and he was Chairman and CEO of Novatel Wireless, a provider of wireless data access solutions for PDA’s and laptops, where he led the company’s successful IPO in the fall of 2000. Before Novatel Wireless, Mr. Major was Chairman and CEO of Wireless Knowledge, a joint venture of QUALCOMM Incorporated and Microsoft Corporation, and held various positions at Motorola, Inc. including Senior Vice President and Chief Technology Officer. At Motorola, his team launched iDEN, the first technology to offer dispatch on cellular and the protocol used by Nextel Communications. Mr. Major currently serves as a director of three public companies: Orbcomm, Lennox International, Inc. and Littelfuse. He Chairs the La Jolla Institute and the University of Illinois Chicago Engineering School Advisory Board. He is Chairman of Pulse Electronics. He was formerly Chairman and Lead Director at Broadcom. Major received a B.S. in Mechanical and Aerospace Engineering from the University of Rochester, an M.S. in Mechanical Engineering from the University of Illinois, an M.B.A. from Northwestern University and a J.D. from Loyola University. He has twelve US patents.

Kathy Ouellette

EvoNexus Vice Chairman, CEO & President, Perma Pure

EvoNexus Vice Chairman // CEO & President, Perma Pure/Maxtec

As a global business leader, Kathy Ouellette's area of expertise is delivering differentiation and value through strategy, process, and product innovation.

Her career consists of commercial and operational roles at Thermo Fisher Scientific, Illumina, and several startups. She previously served as General Manager for a global Thermo Fisher business unit.

Wide-ranging leadership of “blank slate” and turnaround initiatives has been a constant theme of her career. Kathy's experience includes marketing, sales, R&D, manufacturing, and distribution functions, including leading global cross-functional teams. From strategy to execution, she has operations experience in North and South America, EMEA, and Asia-Pacific countries.

Engaging teams to perform their best work is another strength. Kathy thrives in corporate cultures where innovation and integrity are valued, and she represents those values in her customer and company relationships.

Steve Rowles

EvoNexus Secretary, Managing Partner, Morrison Foerster

EvoNexus Secretary / Managing Partner, Morrison Foerster

Mr. Rowles has over 20 years experience as corporate counsel to public and private companies and the venture funds that invest in those companies. Mr. Rowles has extensive industry experience in both the technology and life sciences arenas. Mr. Rowles’ practice includes venture capital financings, venture fund formation, public securities offerings and corporate governance counseling, mergers and acquisitions, and licensing and corporate partnering transactions. He has served as lead counsel on myriad mergers and acquisitions and securities transactions, including public offerings aggregating in excess of $1 billion dollars in proceeds and over 100 acquisition transactions.

Derek Aberle

Co-Founder & Executive Vice Chairman, VIREWIRX

Co-Founder and Executive Vice Chairman, VIREWIRX (formerly XCOM) / Fmr. President, Qualcomm

Derek K. Aberle is Co-Founder and Executive Vice Chairman of VIREWIRX (formerly XCOM), oversees VIREWIRX's strategy, business development, investment activity and operations. VIREWIRX is inventing and investing in wireless technologies to propel the next mobile revolution.

Aberle was formerly the president of Qualcomm Incorporated and was responsible for the oversight for all business divisions across the organization, as well as the company’s global market development and marketing groups. Aberle was also responsible for formulating and driving key strategies for diversifying and growing the company in both Qualcomm’s core businesses, as well as new business opportunities such as data center and mobile healthcare solutions. He served as a member of Qualcomm’s executive committee since 2008, helping to drive Qualcomm’s overall global strategy. In recent years Aberle also has been instrumental to evolving and expanding Qualcomm’s business in China, including leading negotiations with the Chinese Government and establishing important new business ventures in China.

Prior to his role as President, Aberle served as executive vice president of Qualcomm Incorporated, and group president, as well as president of Qualcomm Technology Licensing (QTL). He was responsible for overseeing Qualcomm’s technology and IP licensing business as well as Qualcomm’s earlier stage businesses such as its mobile health, platform, display and wireless charging businesses.

Starting in 2008, Aberle led the QTL division and held several roles within this division, including executive vice president and president, and senior vice president and general manager. He has been instrumental to the success and growth of this division, and, under his leadership, QTL has significantly grown both revenues and profits and established its 4G licensing program. For well over a decade, he has played a leading role in structuring and negotiating key license agreements with Qualcomm’s licensees. He has also contributed heavily to the creation and implementation of the legal and business strategies that led to the resolution of several of the company’s licensing-related disputes.

Aberle joined Qualcomm in 2000 after representing the company as outside counsel for several years at the law firms of Pillsbury Madison & Sutro and Heller Ehrman. Aberle holds a bachelor’s degree in business economics from the University of California, Santa Barbara. He also holds a Juris Doctor from the University of San Diego School of Law, where he graduated magna cum laude.

Ziad Asghar

SVP, Product Management - Snapdragon Technologies & Roadmap, Qualcomm

Senior Vice President, Product Management - Snapdragon Technologies & Roadmap, Qualcomm

Ziad Asghar is senior vice president of product management at Qualcomm Technologies Inc. (QTI). He leads Snapdragon roadmap planning and application processor technologies, covering all smartphone platform products. Ziad drives the definition of products, ensuring that our products lead in technology and enable best-in-class user experiences while making tradeoffs between features, power, performance and cost. He leads application processor technologies including artificial intelligence, camera, graphics, CPU, audio, video and security. He has more than 20 years of experience in the wireless semiconductor industry where he has held a broad set of leadership positions from R&D to product management. Ziad holds an MBA from UCSD and master’s degrees in electrical engineering from Purdue University and Southern Methodist University

Alex Balazs

CTO, Intuit

CTO, Intuit

Alex Balazs oversees Intuit’s technology strategy and leads all of Intuit’s product engineering, data science, information technology, and information security teams worldwide, harnessing advanced technology that helps power prosperity for our customers and partners around the world.

Appointed to the role in September 2023, he is the key driver of our strategy to be the global AI-driven expert platform.

Having joined Intuit in 1999 as a senior software engineer, Alex has worked in almost every part of Intuit’s technology organization. Most recently he was Intuit’s Chief Architect and leader of Intuit’s Platform Acceleration Group, architecting the development of Intuit’s gGenerative AI operating system (GenOS). He also led Intuit’s Futures Team, an organization that uses the latest technology to ensure Intuit’s future success. As Chief Architect, Alex led successful efforts to accelerate developer velocity by expanding and improving Intuit’s platform technology so developers can build world-class innovations with speed.

Prior to Intuit, Alex held engineering roles at Light Lab Imaging and ZEISS Medical Technologies. Alex holds a BSME degree from Kettering University.

Jordan Becker

VP & GM Geospatial Intelligence & ISR, BAE Systems

VP & GM Geospatial Intelligence & ISR, BAE Systems

Jordan Becker is Vice President and General Manager for the Geospatial Intelligence and ISR business area within the Intelligence and Security Sector at BAE Systems, Inc. This business supports solutions for US Government customers within the intelligence and defense communities. GeoINT-ISR is a leader in the development of geospatial intelligence storage and management, and systems for geo-positioning that employ photogrammetry, data analytics and meta-data management for full motion video geo-registration, human geography, airborne vehicle routing, and targeting.

Prior to joining BAE Systems, Inc., Jordan Becker was Senior Vice President at Science Applications International (SAIC) and the Chief Technical Officer for SAIC’s Information Technology and Network Services business. Mr. Becker was responsible for strategic planning, and research & development. Mr. Becker’s Group supported SAIC’s commercial, federal and civil government markets. Mr. Becker was also a senior advisor to BP Corp. Mr. Becker joined SAIC in January 2000 reporting to the CEO and Chairman.Prior to joining SAIC in March 2000, Mr. Becker was Vice President with UUNET Technologies, a global Internet company. Mr. Becker joined UUNET as part of the acquisition of ANS Communications Inc. in 1998. At UUNET, Mr. Becker had responsibility for a 500 person business unit that generated ~$1.2B representing 30% of UUNET revenues at the time. In addition to running the AOL business for UUNET, Mr. Becker managed supplier relationships, Internet technology development, engineering, operations, and planning for services for AOL.

Prior to UUNET, Mr. Becker was one of the founding executives at ANS Communications Inc. in 1990 where he helped grow the company prior to the sale of the company to America Online in February 1995. At ANS Mr. Becker was responsible for service development, engineering, operations, market support, and strategic planning. Mr. Becker assisted AOL with the sale of ANS (a wholly owned subsidiary of AOL) to UUNET Technologies in February 1998. Following the sale of ANS to UUNET, Mr. Becker was the acting ANS CEO overseeing the integration of the company within UUNET.

Prior to the formation of ANS in 1990, Mr. Becker was an Internet pioneer and technologist at IBM Research from 1982-1990 where he received several technology awards and held numerous management positions. Mr. Becker’s responsibilities at IBM Research included engineering and project management for the National Science Foundation Internet backbone (NSFNET), supercomputing systems development, and other information technology projects.

Mr. Becker holds a Master of Science degree in Electrical Engineering from Columbia University, and is a member of the Association of Computing Machinery (ACM), Institute of Electrical and Electronics Engineers (IEEE), a Director of CommNexus San Diego, and a pioneer member of the Internet Society. Mr. Becker is married with 3 children, and lives in San Diego California.

Joe Boerio

EVP, Chief Risk & Transformation Officer, Franklin Templeton Investments

EVP, Chief Risk & Transformation Officer, Franklin Templeton Investments (BEN)

Joe Boerio is the Executive Vice President, Chief Risk & Transformation Officer for Franklin Templeton Investments. As CTO, he has the responsibility for setting and executing the firm’s strategic technology direction for Investment Management, Data Science and Cyber Security. These areas include, investment management DevOps & applications development, data science & analytics, market & alternative data services, FT’s internal FinTech venture, cyber security, enterprise vendor management, rapid development and incubation. Mr. Boerio is a strong visionary global leader passionate about business value and innovative transformations with 30+ years of proven execution results in enterprise information technology, operational excellence and global business enablement. Mr. Boerio is also the Chair of the Investment Company Institute Technology Committee based out of Washington DC and serves on the Board of the FinTech Sandbox in Boston.

Prior to joining Franklin Templeton Investments, Mr. Boerio worked for Mariners Systems, a software development firm that specialized in developing software applications and communication systems focused on infrastructure delivery for worldwide transportation customers.

Mr. Boerio earned his bachelor’s degree in information systems management from the University of San Francisco.

William Eigner

Partner, Business/Technology Team, Procopio

Partner, Business/Technology Team at Procopio, Cory, Hargreaves & Savitch LLP

William Eigner has been called “the go-to guy for M&A and emerging companies” and has often been recognized as a Top Attorney in San Diego.  A partner at Procopio, San Diego’s largest law firm, with offices in Menlo Park, Austin and clients around the world, Eigner’s practice emphasizes venture capital, angel financing, seed capital and the financing, governing, operating, buying, selling and merging of growing and established technology and other businesses. Eigner serves as a director of San Diego Venture Group and of FHOOSH, Inc., an award winning cybersecurity company that protects and powers data for business, government and consumers. He also serves on the board of advisers of Encore Semi, NewBlue Inc. and other companies.  A former U.S. Supreme Court Judicial Intern, Eigner graduated from Stanford and the University of Virginia School of Law.

About Procopio

More about William Eigner

Dana Escobar

CLO & GM, Semiconductor, Adeia

Chief Licensing Officer & General Manager - Semiconductor, Adeia

Dana Escobar is the Chief Licensing Officer and General Manager – Semiconductor for Adeia. Prior to the spin-off of their product business, Xperi Inc., from Adeia's IP licensing business in 2022, he served as Senior Vice President and General Manager of Semiconductor IP at Xperi Holding Corporation (renamed Adeia Inc. at the time of the spin-off). Dana joined the company in 2020 as Vice President of IP Licensing. Prior to joining Xperi, Dana was Vice President of IP Licensing at GE, Chief IP Counsel at Sharp Laboratories of America and Director of Sharp Corporation's U.S. IP Center, Senior Director of IP Licensing at LSI Corporation/Avago, Licensing & Litigation Attorney at Discovision Associates, and a Deputy District Attorney in Los Angeles County.Dana holds a Juris Doctor from the University of California Los Angeles, School of Law and a B.A. degree in political science from the University of California, Los Angeles.

Burton Goldfield

President & CEO, TriNet

President & CEO, TriNet

Since 2008, Burton M. Goldfield has served as president and CEO of TriNet, a strategic partner to small businesses for payroll, HR, benefits, employment law compliance and risk reduction. Burton has more than 25 years of experience in sales, operational, and technology leadership positions and is known for driving product innovation and business growth. Since joining TriNet, Burton has transformed the company into the largest independent cloud-based HR provider and Professional Employer Organization (PEO). With offices throughout America, TriNet serves more than 8,000 customers and over 210,000 employees. Its services allow small businesses to regain focus on executing their visions and growing their businesses while TriNet manages their payroll taxes, day-to-day HR, employment law compliance, and conformity with the Affordable Care Act. TriNet’s revenue exceeded $250M in 2012 and has more than tripled during Burton’s tenure. To expand TriNet’s market reach and strengthen the company’s ability to serve more clients than ever before, he led the company to acquire LMC, Gevity, AccordHR, SOI and ExpenseCloud. In addition, Burton invested heavily in the company’s Software-as-a-Service (SaaS) technology platform, leveraging his background from Hyperion, IBM, and Rational Software. Prior to TriNet, Burton was CEO at Ketera Technologies, a Santa Clara-based SaaS provider to FORTUNE 2000 companies. Before that, Burton served as senior vice president, worldwide field operations at Hyperion Solutions Corporation and vice president of worldwide sales for IBM Corporation’s Rational Software division. Burton received a bachelor’s degree in biomedical engineering from Syracuse University and an MBA from Villanova University. In 2010, the San Francisco Business Times named him a Most Admired CEO.

Paul Hartke

Fellow, AMD

Fellow, AMD

Paul Hartke is now a Fellow in AMD Research and Advanced Development (AMD). Prior to the AMD acquisition of Xilinx in 2022, he was a member of the Xilinx Chief Technology Office which had responsibility for advanced technology development across the Xilinx adaptive computing portfolio. His pathfinding interest is the intersection of compute, networking, and storage spanning from embedded systems to data center architectures.

Dong-Su Kim, Ph.D.

CEO & Board Member, Corporate EVP, LG Technology Ventures

CEO & Board Member, Corporate EVP, LG Technology Ventures

Dong-Su Kim is the CEO and board member of LG Technology Ventures. He has over twenty-five years of investment, strategy, planning, and technology experience. As the founding CEO, Dong-Su established the fund structure, hired key people, and initiated investment operations. Under his guidance, LG Technology Ventures manages over $400 million of fund assets and invests in early-stage information technology, automotive, manufacturing, life-sciences, energy, and advanced materials companies. Portfolio companies include AmazeVR, Lygos, May Mobility, and Ridecell. Dong-Su Kim was also recently promoted to corporate Executive Vice President.

Previously, Dong-Su was Vice President and GM of Samsung Ventures America where he managed offices in Menlo Park, Boston, London, and Tel Aviv. He has led the investment of over thirty companies in diverse sectors including semiconductors (Soft Machines, Verisilicon, Wave Computing), equipment (DCG Systems, IMS, Reno Subsystems), materials (Nanosys, NexPlanar, Voltaix), and storage systems (Pure Storage).

Prior to joining Samsung Ventures, he was a Director at Asia Evolution, an investment bank in Korea covering mid-market financing, private placement, and M&As.

Before that, he was a Director at the Technology Strategy Office of Samsung Electronics. As the CTO’s staff, he was responsible for strategic venture investments and technology alliances. He also worked in technology planning for Samsung’s Telecom R&D center, responsible for discovering new research topics. Dong-Su started his professional career as a Technical Leader at Samsung Fiber Optics Business Unit in development of fiber optic components.

His past Board Director appointments include Datera, Digital Specialty Chemicals, Femtometrix, Inpria, Reno Subsystems, SBA Materials, SVXR, D2S, DCG Systems (acquired by FEI), NexPlanar (acquired by Cabot), Voltaix (acquired by Air Liquide), Panasas, and Pixtronix (acquired by Qualcomm). Dong-Su also served on the Investment Advisory Committee for Sierra Ventures.

Dong-Su has earned an M.A. and a Ph.D. in Electrical Engineering from Princeton University, and a B.S. with Honors in Applied Physics from California Institute of Technology.

Dr. Richard Kurtz

VP Corporate Business Development, Bio-Rad

Vice President, Corporate Business Development, Bio-Rad Laboratories

Richard Kurtz, Ph.D. is the Vice President of Corporate Business Development for Bio-Rad Laboratories, a life science research and clinical diagnostics company that has been serving customers worldwide since 1952. In his current role, Richard reports to the company’s Chief Strategy officer and executes corporate strategies to deliver long-term company growth, focusing on acquisitions, partnerships and technology licensing in both Life Science and Clinical Diagnostics. Richard also coordinates Bio-Rad Corporate Venture Fund investments in start-up companies with innovative products and technologies focusing on research, diagnostics and health care.

Richard has 15 years of industry experience. Previously, Richard was the Marketing Director for the Life Science Gene Expression Division, a role in which he managed long-term product-line strategies, product development and global commercialization activities for one of Bio-Rad’s largest Life Science product portfolios. He has extensive experience in strategic business planning, technology assessment, product development and commercialization. Richard received his Ph.D. in Molecular Biology from Northwestern University prior to transitioning into industry.

BIO : (NYSE) Bio-Rad Laboratories, Inc. develops, manufactures, and markets a broad range of products for the life science research and clinical diagnostics markets.

John Langan, PhD

CTO, EMD Electronics

Chief Technology Officer at the Electronics Business of Merck KGaA, Darmstadt, Germany (EMD Electronics)

John is a seasoned innovation expert in the semiconductor industry with over 35 years of experience in R&D with a deep passion for innovation and technological advancement. As the Chief Technology Officer of the Electronics business of Merck KGaA, Darmstadt, Germany, John oversees the development and execution of the business sector’s technology strategy, ensuring that they remain at the forefront of the industry and meet their customers' ever-changing needs.

John began his career at Air Products in 1988. Over the next decade, he took on various roles within the organization, including Research Scientist, Technology Manager, and Business Development Manager. In 2000, John joined Lam Research as Director of Technology. In 2005, he returned to Air Products to become the company’s Electronics Division Head of R&D. He became Chief Technology Officer of Versum Materials after that division spun out of Air Products. He kept this position when the company was later acquired by Merck KGaA, Darmstadt, Germany, a vibrant science and technology company that operates in three business sectors – Healthcare, Life Science and Electronics. In the United States and Canada, the Electronics business sector operates as EMD Electronics.

John holds a PhD in Physical Chemistry from Columbia University and was a post-doctoral associate at MIT. He’s based in Carlsbad, California.

John “Rick” LeMoine, MD

CMIO, Sharp HealthCare

Chief Medical Information Officer, Sharp HealthCare

John R. (Rick) LeMoine, MD, FACP, is the chief medical information officer for Sharp HealthCare. He is responsible for providing medical direction and physician counsel for Clinical Effectiveness and Information Systems.

A graduate of Dalhousie Medical School in Nova Scotia, Canada, Dr. LeMoine completed his fellowship program in pulmonary and critical medicine at the University of California, San Diego (UCSD). He has served on the faculty of medicine at both Dalhousie University and UCSD.

Prior to his current role at Sharp HealthCare, Dr. LeMoine held leadership roles with the Medical Society of Nova Scotia and the Canadian Medical Association. He also served as executive director for insured programs and clinical rationalization for the government of Nova Scotia.

Dr. LeMoine has had a keen interest in clinical information systems since joining Sharp HealthCare in 1982. His research interests and activities have included pulmonary and venous thromboembolism and community-acquired pneumonia.

Dr. Quinn Li

SVP & Global Head, Qualcomm Ventures

SVP & Global Head, Qualcomm Ventures

Quinn oversees Qualcomm’s $1B global venture investment portfolio of 150+ companies across seven global regions. Quinn and his team invest in key areas such as 5G, AI, Automotive, IoT and Networking to help expand Qualcomm’s ecosystem of customers and partners. He currently serves as a board member or observer in Airspan, ClearMotion, Cohesity, Innovium, Pensando and RetailNext. Quinn has led over a dozen investments with successful exits in A123 Systems, Eero, InvenSense, Powercloud Systems and Zoom.

Quinn started his career as an engineer working on 3G wireless technology and standards development at Lucent Technologies. Prior to joining Qualcomm Ventures, he worked in product management and business development in IBM Systems and Technology Group. Earlier, he worked on wireless technology development at Broadcom.

Quinn received his MBA from Cornell University, and his B.S., M.S. and Ph.D. in Electrical Engineering from Washington University in St. Louis.

David Marino

Co-Founder & Senior EVP, Hughes Marino

Co-Founder & Senior EVP, Hughes Marino

David Marino is a principal and senior executive vice president of Hughes Marino, the largest tenant representation company in San Diego. David specializes in high-value, time-critical and complex transactions for technology, life science and business service companies. He is an expert in the strategic planning, market assessment, financial analysis, business terms structuring and negotiations aspects of commercial real estate. David is a licensed California Real Estate Broker and has been exclusively representing tenants since 1991, completing over 11,000,000 square feet, comprised of over 1,000 transactions. Between 1989 and 1991, David worked at Trammell Crow Company, then the largest commercial real estate owner in the U.S. where he learned the business from the landlord side of the table. David has a broad business background as an early stage angel investor in over twenty companies and is a LP in venture capital funds including Mission Ventures, Windward Ventures, Hamilton Bioventures and Avalon Ventures.

Craig Miller

President, Global Space Networks, Viasat

President, Global Space Networks, Viasat

Craig Miller leads our Global Space Networks organization. Craig joined Viasat in 1995, and has held numerous technology, business and strategic leadership roles including: President of Government Systems, the segment’s Chief Technology Officer where he was responsible for establishing and communicating the technical strategy and roadmaps for a diverse portfolio of defense products and services: including satellite communications, tactical networks, information assurance, cyber/network security and Intelligence, Surveillance and Reconnaissance.

Craig also launched the Viasat Government Systems Space Business, developing Link 16-enabled LEO satellites; creating a space-to-space relay technologies for NASA’s CSP Program; building out Viasat’s mobile satellite communications ground gateway systems; and advancing Viasat’s Hybrid Adaptive Network capabilities.

Prior to Viasat, Craig worked at Hughes Missile Systems Group in Tucson, Arizona, where he was responsible for implementation of Electronic Counter Measures for the AAMRAM Missile System. Craig holds a Bachelor of Science in Electrical Engineering, with emphasis on Communications and Signal Processing from the University of Arizona.

Bardia Moayedi

Partner, Snell & Wilmer

Partner, Snell & Wilmer

Bardia Moayedi is a corporate and securities partner, chair of the firm’s Technology Industry Group and co-chair of the firm's Life Sciences Industry Group. He primarily advises emerging growth and public companies throughout their life cycles as well as venture capital and private equity firms, particularly in the life sciences, high-technology, financial technology, food and beverage, and clean-technology industries.

Bardia has significant experience representing companies and financial firms in a broad range of general corporate governance and transactional matters, including venture capital financings, mergers and acquisitions, debt offerings, spin-offs/divestitures, joint ventures, IPOs, follow-on offerings, and tender offers. He is a trusted advisor, often serving as the go-to outside counsel or lead counsel to his clients.

Prior to attending law school, Bardia worked at a prominent investment bank, where he focused on hedge funds and private equity funds. As an undergraduate, he played ice and roller hockey at UCLA.

Zachary Myers

Partner, Wilson Sonsini Goodrich & Rosati

Partner, Wilson Sonsini Goodrich & Rosati

Zach Myers is a partner at Wilson Sonsini Goodrich & Rosati where he specializes in corporate and securities law, including mergers and acquisitions, venture capital financings, and general corporate representation. He represents private and public companies in the technology and life sciences sectors—especially biotechnology and medical device companies—in complex, high-value transactions.  He has represented a number of leading companies in venture capital financings, helping them raise millions of dollars needed to fund, grow, and expand their businesses. He has also assisted numerous clients that have gone public, listing on the New York Stock Exchange and NASDAQ markets.

Rodd Novak

VP Corporate Planning & Development, pSemi

VP Corporate Planning & Development, pSemi

Rodd Novak is the VP of Corporate Planning and Development for pSemi Corporation with more than 20 years of executive-level experience.  A well-rounded corporate strategist, he has successfully built and led international business divisions from inception to profitability.  Rodd originally joined pSemi in 2002 and held multiple positions including Chief Marketing Officer, VP of Marketing, Sales and Business Development.  Under his leadership, pSemi increased revenue at a 30% CAGR for 10yrs, created three business units and expanded its global sales network. Before that, Rodd held positions with CTS Corporation, Northrop Grumman/Xetron and interned at Comsat Laboratories. Rodd received his bachelor’s degree in electrical engineering from the University of Cincinnati and his MBA from Xavier University.

Carlos Nunez, M.D.

CMO, ResMed

Chief Medical Officer, ResMed

Carlos M. Nunez, M.D., was appointed ResMed’s chief medical officer in January 2017. Prior to joining ResMed, he was senior vice president of Medical Affairs at Becton, Dickinson and Company, leading the Office of Science, Medicine and Technology for its largest division. Before that, he was chief medical officer at CareFusion, where he built and led a global team that provided company-wide medical oversight.

From 2000 to 2011, Carlos was chief physician executive at Picis, Inc., an industry-leading medical informatics company that became part of the Optum division of UnitedHealth Group. At Picis/Optum, Carlos provided medical leadership and clinical direction for corporate strategy, marketing, product development, sales, implementation and customer relations for global markets.

Before working in the medtech industry, Carlos was a practicing anesthesiologist, intensivist and hospitalist; director of critical care research, informatics and analytics; and the Duke University educational affiliation at Carolinas Medical Center NorthEast.

Carlos received his medical doctorate from the University of Miami School of Medicine, where he also completed his postgraduate training in anesthesiology, critical care medicine and clinical research.

Eddy Ortiz

VP of Innovation & Solution Acceleration, Royal Bank of Canada

VP of Innovation & Solution Acceleration, Royal Bank of Canada

 Eddy, the Vice President of Solution Acceleration & Innovation at RBC, is responsible for driving disruptive digital innovation. With labs in Toronto, San Francisco, London, Luxembourg, New York & Orlando, RBC is partnering with a diverse set of players, including startups & academia, to access & drive emerging trends.

For almost 20 years, Eddy has been key in leading RBC’s digital strategy, including the launch of the first mobile banking application, the invention & patent of Secure Cloud technology, and maintains uniquely strong relationships with Silicon Valley.

Rajesh Pankaj, Ph.D.

EVP, CTO, InterDigital

EVP, Chief Technology Officer, InterDigital

 Rajesh Pankaj is InterDigital’s EVP, Chief Technology Officer. In this role, he is responsible for leading the company’s technology vision and strategy and advancing the company’s technology roadmaps. Dr. Pankaj works closely with other executives to partner with internal R&I efforts, external investments and corporate development in executing the company’s technology vision.

Dr. Rajesh Pankaj is an inventor and a technology executive with deep expertise in wireless research in 3G, 4G and 5G and in emerging areas like deep learning. He joined InterDigital in July 2022 from Qualcomm where he oversaw research in 5G, 4G LTE, augmented reality and other technologies, contributing to an industry-leading wireless and mobile computing patent portfolio. During his 25-year tenure, Dr. Pankaj most recently served as Senior Vice President of Engineering and Head of Corporate R&D, managing a global team of engineers focused on Artificial Intelligence, Edge Computing and new technologies.

A prolific innovator, Dr. Pankaj is an inventor or co-inventor on 230 patents worldwide.

Dr. Pankaj holds a Ph.D. and a master’s degree in electrical engineering and computer science from the Massachusetts Institute of Technology and a bachelor’s degree of technology in electrical engineering from the Indian Institute of Technology.

Dr. Karthik Ranganthan

WW VP, Alaris Business Leader, BD

WW VP, Alaris Business Leader, Becton Dickinson

Karthik leads global ~$1B Alaris infusion business, including capital equipment, interoperability, and analytics offerings. During his 14 years at Becton Dickinson, Karthik has held many positions ranging from Manager of Advanced Concept Development all the way to Vice President. He is an experienced leader of large global healthcare businesses. Karthik is comfortable with conceptualizing, launching, and scaling “new to the world” innovation, as well as managing large and mature businesses. Before working at BD, Karthik held the position of Research Scientist at PocketSonics, Inc. He was the first full-time employee of the company, and he helped lead R&D and played a key role in designing and building PocketSonics’s device. Karthik also co-invented a patent on novel ultrasound signal processing during this time.

Karthik received his MBA in General Management from Harvard’s Business School. He also holds a PhD from the University of Virginia in Biomedical Engineering. It was here that he performed his independent dissertation research on ultrasound imaging systems.

Eric Reed

SVP, Sales and Distribution, TriNet

SVP, Sales and Distribution, TriNet

Eric serves as the VP, Channel Sales overseeing the national channel strategy for TriNet. In this capacity, Eric works to develop key partnerships and alliances that enable top line growth through the partner ecosystem.

Prior to this role, Eric served as the VP, Sales Enablement where he designed and stood up a high-performing, nationwide Sales Development organization to drive top of funnel lead generation. Eric also oversaw curriculum, content curation and delivery of all L&D programs for sellers and sales leaders.

Further, Eric drives his teams to empower and enable entrepreneurs of small and medium-sized businesses to do their ‘why’.

As a collaborative and innovative senior leader, Eric has extensive experience driving business growth, transformation, and sustainability for high-profile Technology organizations.

Before TriNet, Eric spent almost 20 years at Verizon and held multiple senior leadership roles within the organization.

Prior to leaving Verizon, Eric was the Consumer Vice President where he led consumer distribution and operations for the West Region.

Eric received a Bachelor's Degree in Psychology from Biola University.

Kenneth Rollins

Partner, Cooley LLP

Partner, Cooley LLP

Mr. Rollins has a general corporate transactional practice, representing emerging and late stage private companies and public companies in a wide range of corporate and securities matters, including private financings, public offerings, mergers and acquisitions, tender offers, strategic collaborations, commercial agreements, corporate governance matters, and employment and compensation arrangements. He also advises venture capital firms in connection with financings and other transactions.

Mr. Rollins is counsel to companies in diverse industries, including information technology, biotechnology, medical device, retail, semiconductor, software and cleantech. His clients range from start-ups to public companies with hundreds of millions of dollars in annual revenues.

Todd Stallard

GM US IoT, Sigma Connectivity

General Manager - US IoT, Sigma Connectivity

With over 20 years of experience in the tech industry, Todd Stallard leads and scales high-performance teams across various domains and regions. As the GM- US IoT at Sigma Connectivity, he oversees a diversified portfolio of services that address multiple verticals, such as MedTech, automotive, supply chain, wearables, climate tech, agriculture tech, and consumer devices. Todd helps clients innovate, create value, and grow with connected solutions and devices that leverage 5G IoT, RF connectivity design, mechanical, and optoelectronics.

He’s also a founding member of the Holomedicine Association, a pioneering organization that promotes the use of augmented, mixed, and virtual reality for practicing and delivering medicine through sensory camera technology. Todd uses his skills and expertise in experiential marketing, product marketing, strategy, and innovation to drive customer success and satisfaction, and to build long-term relationships with partners and clients. He is motivated by the mission to positively impact the world with cutting-edge technology and human-centric design.

Mehul Udani

VP of Corporate Technology & Innovation, Murata Americas

Vice President of Corporate Technology & Innovation, Murata Americas

Mehul is focused on leveraging the innovation continuum to drive Murata’s growth in North America. From ideation to implementation, this includes new business creation, incubation, investment opportunities, and strategic partnerships. His market areas of expertise intersect numerous industries: healthcare, energy, mobility, connectivity, and wireless.

Mehul has 25 years of Semiconductor, Wireless, Sales, Technical Marketing and Business Development experience. He has a proven track record for cultivating business in new segments, launching new product strategies, creating successful business partnerships, and growing revenue.

He received his BS in electrical engineering from the University of Maryland and MS from Johns Hopkins University.

Mentors/ Selection Committee Members

Steve Rowles

Steve Rowles

EvoNexus Secretary, Managing Partner, Morrison Foerster
Marco Thompson

Marco Thompson

Partner, Express Ventures
Mike Benvenuti

Mike Benvenuti

Fund Manager, Cove Fund
Jeff Bocan

Jeff Bocan

Partner, Okapi Venture Capital
Andrew Bolwell

Andrew Bolwell

Chief Disrupter and Global Head of Tech Ventures and Incubation, HP, Inc.
Arun Chetty

Arun Chetty

Managing Director, Intel Capital
Jeff Cunningham

Jeff Cunningham

Senior Investment Manager, Lockheed Martin Ventures
William Eigner

William Eigner

Partner, Business/Technology Team, Procopio
Daniel Franke

Daniel Franke

Investment Director, M Ventures
Jason Halac

Jason Halac

Senior Director, Dexcom Ventures
Tim Hoerr

Tim Hoerr

CEO & Managing Partner, Serra Ventures
Henry Huang

Henry Huang

Investment Director, TDK Ventures
Kanaan Jemili, PhD

Kanaan Jemili, PhD

Co-Founder & CEO, Visaic
Prashant Kantak

Prashant Kantak

Mentor, Former Founder, Qualcomm Ventures
Pankaj Kedia

Pankaj Kedia

Founder & Managing Partner, 2468 Ventures
Dong-Su Kim, Ph.D.

Dong-Su Kim, Ph.D.

CEO & Board Member, Corporate EVP, LG Technology Ventures
Ashok Kamal

Ashok Kamal

Executive Director, NuFund
Carlos Kokron

Carlos Kokron

VP & Managing Director, Qualcomm Ventures
Masashi “Mac” Kubota

Masashi “Mac” Kubota

Corporate Venturing Manager (CTO function), Murata
Dr. Quinn Li

Dr. Quinn Li

SVP & Global Head, Qualcomm Ventures
Howard Mirowitz

Howard Mirowitz

Manager, Cove Fund II
Oliver Mitchell

Oliver Mitchell

Venture Partner, ff Venture Capital
Robert Mittendorff, M.D.

Robert Mittendorff, M.D.

General Partner & Head of Healthcare, B Capital Group
Zachary Myers

Zachary Myers

Partner, Wilson Sonsini Goodrich & Rosati
Nandhu Nandhakumar

Nandhu Nandhakumar

CTO, Alat, Former SVP, Office of the CTO, LG Electronics
Michael Nowak, PhD

Michael Nowak, PhD

Managing Partner, Nowak Ventures
Kenneth Rollins

Kenneth Rollins

Partner, Cooley LLP
J.C. Ruffalo

J.C. Ruffalo

Venture Partner, Cove Fund
Brad Schoening

Brad Schoening

Executive Director, JPMorgan Chase & Co.
Ben Strom

Ben Strom

Venture Partner, Impact Venture Capital
Hem Suri

Hem Suri

EvoNexus Fintech Executive In Residence, Founder & Managing Partner, Spark Growth Ventures
Richard Tapalaga

Richard Tapalaga

Partner, Qualcomm Ventures
Andy Taylor

Andy Taylor

Mentor, Former VP & GM, Home New Ventures, Credit Karma
Dr. Paul Voois

Dr. Paul Voois

Managing Partner, Cove Fund
Albert Wang

Albert Wang

Senior Investment Director, Qualcomm Ventures

Steve Rowles

EvoNexus Secretary, Managing Partner, Morrison Foerster

EvoNexus Secretary / Managing Partner, Morrison Foerster

Mr. Rowles has over 20 years experience as corporate counsel to public and private companies and the venture funds that invest in those companies. Mr. Rowles has extensive industry experience in both the technology and life sciences arenas. Mr. Rowles’ practice includes venture capital financings, venture fund formation, public securities offerings and corporate governance counseling, mergers and acquisitions, and licensing and corporate partnering transactions. He has served as lead counsel on myriad mergers and acquisitions and securities transactions, including public offerings aggregating in excess of $1 billion dollars in proceeds and over 100 acquisition transactions.

Marco Thompson

Partner, Express Ventures

Partner, Express Ventures / Former CEO & Founder, Doctor Design (acquired by WindRiver/Intel)

Thompson co-founded & ran CommNexus San Diego, (formerly San Diego Telecom Council) a non-profit network of communications, government, and defense industry companies. A familiar face in the boardrooms of a number of innovative San Diego concerns, Thompson will call on over thirty years of engineering services management experience and a vast network of technology contacts and affiliations to direct the technology focus for the Sorrento Valley engineering services company.

Thompson has designed and managed his way to entrepreneurial success. In 1984 he founded Doctor Design, an embedded engineering services firm that contracted for such companies as AMD, Intel, Samsung, Mitsubishi, DIRECTV, Philips, Thomson, Sony, and IBM. Thompson would later sell the $50 million firm to Integrated Systems, which merged with Wind River (WIND) in 2000, and then merged with Intel (INTC) in 2009. Thompson stayed with the firm for 25 years before departing in November of 2009. Although trained only as an engineer, and not a marketer or manager, Thompson credits the exceptional strength of UCSD and the entrepreneurial network of San Diego for the success of his former firm. “We reached 250 people because UCSD taught great basic engineering and thinking skills and because the San Diego community is great at networking and providing mentoring to promising entrepreneurs."

Prior to joining Solekai, Thompson co-founded & ran CommNexus San Diego, (formerly San Diego Telecom Council) a non-profit network of communications, government, and defense industry companies. Thompson is also currently a Managing Partner at Express Ventures, an early stage Venture Capital Firm, which has funded eight San Diego companies. In addition, Marco is the founder & Vice Chairman of San Diego Sport Innovators, and is the Vice-Chair of the Board of Connect, San Diego’s startup assistance organization. Thompson earned his BSEE, in Applied Physics & Information Systems in 1979 from the University of California at San Diego. In 2003, Thompson was named the Alumni of the Year by the UCSD Jacobs School of Engineering and further honored by being inducted into the Hall of Fame for Engineering, Science and Technology. His interests include heli-skiing, wakesurfing, hockey, and snowboarding.

Mike Benvenuti

Fund Manager, Cove Fund

Fund Manager, Cove Fund

Mike Benvenuti is a Fund Manager with Cove Fund, an active Expert in Residence at UCI Applied Innovation, and an advisor or board member with several early-stage startups. Mr. Benvenuti was previously a service sector business executive with a long history in recurring revenue business where keeping customers for life is the key to building shareholder value. In 1985, he joined the nascent wireless industry, was an early-stage employee for PacTel Cellular that had an IPO as AirTouch in 1994 and was purchased by Vodafone in 1999 for approximately $60B. Subsequently, he held positions of Senior Vice President, Divisional President and Chief Operating Officer for both private and publicly held companies in the education sector. Mr. Benvenuti received a BS (cum laude) in Civil Engineering and an MBA in Finance from UC Irvine.

Jeff Bocan

Partner, Okapi Venture Capital

Partner, Okapi Venture Capital

Jeff is Okapi’s lead on our investments in Candid Wholesale, TrackStreet, WhiteFox Defense Technologies, Nimble for Good, CLI Studios, Trellis Research, Daasity, WeGive, Network Perception, Trnsact and Chargezoom.

Prior to joining Okapi as a Partner in Okapi’s third fund, Jeff worked has served as venture capitalist since 2001, having invested $100+M in 40+ companies and having served on the boards of 25 businesses.

In addition to his VC experience, Jeff had 3+ years of operating experience helping lead the scaling of a rapidly growing tech startup, Mophie. Jeff was the original VC investor in Mophie and served on the board before joining the Executive team full time to help manage the company’s rapid growth and global expansion. Jeff helped grow Mophie’s revenue from <$10 million in 2010 to $250+ million in 2015, and to the eventual sale of the company in early 2016 to ZAGG (NASDAQ: ZAGG).

Prior to joining Mophie, Jeff was a Managing Director at Beringea for 11 years where he sourced, led or managed the technology and media investments for 30 of Beringea’s portfolio companies and served on 22 corporate boards across several of Beringea’s $50 – $150 million venture funds; including such companies as: Mophie (Acquired: ZAGG), Mergermarket (Acquired: Pearson) and Sakti3 (Acquired: Dyson).

Jeff was also one of two angel investors in Duo Security (Acquired: Cisco – $2.4B – a 100+x return) and has made other promising angel investments, including Acorns. His work prior to Beringea included an early-stage tech VC in London (Saffron Hill Ventures), and marketing roles for BMW of North America and startup beverage company, Honest Tea.

Jeff also has served as a Lead Instructor of the National Science Foundation’s I-Corps Program, teaching at Stanford University and the University of Michigan. Additionally, during his venture capital career, Jeff was a contributing blogger for The Huffington Post — his series focused on technology and venture investing in the Midwest.

Jeff earned a B.A. in Government and Sociology from the University of Notre Dame, graduating magna cum laude and Phi Beta Kappa; and a Master of Business Administration with high honors from the University of Virginia. Jeff currently resides Newport Beach, CA with his wife and four children.

Andrew Bolwell

Chief Disrupter and Global Head of Tech Ventures and Incubation, HP, Inc.

Chief Disrupter and Global Head of Tech Ventures and Incubation, HP, Inc. 

 Andrew Bolwell is Chief Disrupter and Global Head of Tech Ventures and Incubation at HP where he drives new business creation for HP's Strategy and Incubation Office, and is Managing Partner of HP Tech Ventures, the corporate VC arm of Silicon Valley’s original startup.  In this role Andrew and his team drive new business creation activities for HP to identify and launch new market segments, products and business models that will help shape HP’s future growth.

As Managing Partner for HP Tech Ventures, Andrew is responsible for HP’s partnership and investment activities with start-ups.  With teams in Palo Alto and Israel, HP Tech Ventures makes early-stage investments in the world’s leading start-ups in industry shifting technology areas including Artificial Intelligence, Advanced Manufacturing, Security, Digital Health, VR/AR, Gaming & eSports, and 3D Printing.

As one of HP’s lead futurists, Andrew is also responsible for HP thought leadership and industry evangelism. In this role Andrew is a sought-after keynote speaker, recognized futurist, blogger and HP spokesperson for global megatrends, new business creation, innovation, emerging technology trends and new, disruptive technologies.  He has been widely quoted in the New York Times, USA Today, The Financial Times, The Economist, Reuters, CNET, Information Week and Le Monde, among others. He has also appeared as a spokesperson and industry expert on ABC News with Charles Gibson and ABC News Now, and featured on BBC’s Tech Tent.

Prior to this role, Andrew was General Manager of a number of successful HP businesses, including co-founder and CEO of MagCloud, an online self-publishing service that Andrew helped incubate and grow from concept to a high-growth, multimillion-dollar business.

Andrew is a graduate of the Venture Capital Executive Program at the University of California, Berkeley, Haas School of Business, and the Accelerated Leadership Executive Program at Harvard Business School. He graduated magna cum laude from Monash University, where he earned a Bachelor of Science degree in Computer Science with first class honors. A native Australian, Andrew has lived and worked in the US, Australia, and Japan. He currently resides in Santa Cruz, California with his wife and two daughters.

Arun Chetty

Managing Director, Intel Capital

Managing Director, Intel Capital

Arun Chetty is a Managing Director at Intel Capital and is based in the Bay Area. He joined Intel Capital in 2004.

Arun is focused on investments related to Edge AI, 5G / Communications, Gaming, AR/VR, PC Client platform and related Enterprise Software opportunities. He has led Intel’s investments in companies such as VeriSilicon (IPO), Bluestacks, Teikametrics, Babble Labs, Telink and NextInput.

Arun currently serves as a Board Director or Observer on the Boards of Bluestacks, Cambridge Mechatronics Ltd., Teikametrics, Avaamo, OnScale, and AdHawk Microsystems, and also manages Intel Capital’s investments in Untether.ai and Syntiant.

Prior to Intel Capital, Arun was a Director of M&A in Intel’s Corporate Development group and Controller in Intel’s Finance organization. Prior to his MBA from the University of Michigan, he was a Process Engineer at Intel, DuPont and Brookhaven National Labs. He received his Bachelors of Engineering and Masters of Engineering from Princeton and MIT, respectively. Arun has traveled with his family to 32 countries in 6 continents and loves to do altitude climbs on his road bike.

Jeff Cunningham

Senior Investment Manager, Lockheed Martin Ventures

Senior Investment Manager, Lockheed Martin Ventures

Jeff Cunningham leads venture capital investments across a variety of technology disciplines including missile and fire control technologies, semiconductor and next-generation electronics, advanced communications and 5G, advanced energy solutions, precision navigation and timing and sensor technologies.

Prior to joining Lockheed Martin Ventures, Mr. Cunningham served as a finance lead for a $4.6 billion Lockheed Martin program supporting the Department of Defense’s global data network. As one of the first employees on the program, he helped grow the contract into one of the largest and most profitable programs in the Information Systems & Global Solutions business area. Mr. Cunningham has served in various roles with Lockheed Martin including corporate development, program management finance, and financial planning and analysis.

Mr. Cunningham earned his master’s degree in Business Administration from the University of Maryland and his bachelor’s degree from Virginia Tech.

William Eigner

Partner, Business/Technology Team, Procopio

Partner, Business/Technology Team at Procopio, Cory, Hargreaves & Savitch LLP

William Eigner has been called “the go-to guy for M&A and emerging companies” and has often been recognized as a Top Attorney in San Diego.  A partner at Procopio, San Diego’s largest law firm, with offices in Menlo Park, Austin and clients around the world, Eigner’s practice emphasizes venture capital, angel financing, seed capital and the financing, governing, operating, buying, selling and merging of growing and established technology and other businesses. Eigner serves as a director of San Diego Venture Group and of FHOOSH, Inc., an award winning cybersecurity company that protects and powers data for business, government and consumers. He also serves on the board of advisers of Encore Semi, NewBlue Inc. and other companies.  A former U.S. Supreme Court Judicial Intern, Eigner graduated from Stanford and the University of Virginia School of Law.

About Procopio

More about William Eigner

Daniel Franke

Investment Director, M Ventures

Investment Director, M Ventures

Daniel Franke, Investment Director in the Technology team, joined M Ventures as an Associate in 2019, after supporting the team as an Analyst as part of the M Ventures Fellowship. Daniel obtained his Bachelor’s and Master’s in Chemistry at RWTH Aachen University before moving on to the Massachusetts Institute of Technology for his Ph.D. studies. At MIT, Daniel developed functional materials for display technologies and advanced biomedical imaging applications, leading to a pending patent application for a novel biomedical imaging platform on basis of shortwave infrared light. Daniel is based in Boston.

Jason Halac

Senior Director, Dexcom Ventures

Senior Director, Dexcom Ventures

Jason is the co-founder of Dexcom Ventures where he leads technology scouting and strategic pipeline development.  He is a seasoned innovator in the medical device field and a key contributor in Dexcom product development over the past decade.

Committed to Dexcom’s mission of ”Empowering people to take control of diabetes" he has advanced the simplicity, reliability, and comfort of Dexcom’s continuous glucose monitoring systems.  Jason has been a prolific inventor and is named on well over 100 worldwide patents and patent applications.

With Dexcom Ventures, Jason is chartered with building a portfolio as value-added strategic investors by leveraging access to Dexcom’s unique industry expertise and technology leadership.

Prior to Dexcom, Jason held a variety of engineering and leadership roles as a consultant and with Black and Decker.  He holds a B.S. in mechanical engineering from San Diego State University.

Tim Hoerr

CEO & Managing Partner, Serra Ventures

CEO & Managing Partner, Serra Ventures

Tim Hoerr is a seasoned business executive with nearly 40 years of experience in a variety of industries. He serves as the CEO and Managing Partner of Serra Ventures, which he founded in 2008. He was co-founder and former CEO of iCyt Mission Technology, Inc., a highly successful bio-instrument company that won numerous awards for technology and business excellence and which was acquired by Sony Corporation in late 2009. Tim was awarded the Entrepreneurial Excellence in Management Award at the Innovation Celebration, 2009. Prior to iCyt, Tim was the President and CFO of SourceGear, an early internet browser company focused on mobile devices. Subsequent to his tenure at SourceGear and iCyt, he served as the CEO of ImmuVen, a drug development company that was acquired by a large pharmaceutical company in 2014.

Tim spent nearly all of the first 15 years of his professional career with RSM McGladrey (now RSM) in Illinois and San Diego, leading teams of consultants focused on serving middle market clients. In his capacity as Consulting Partner with McGladrey, Tim provided leadership on a regional and national level. He also served on two national committees for the American Society of Certified Public Accountants (Business Valuation and Emerging Services). A published author and former professional speaker, he has given over 300 speaking and workshop presentations in his professional career.

Professional Credentials: Tim holds the Certified Public Accountant (CPA, 1983) and Certified Management Accountant (CMA, 1984) designations. He received national honors on both the CPA and CMA examinations. He formerly held the Accredited Senior Appraiser of Business Valuation credential (American Society of Appraisers) while actively practicing business valuation as a partner in RSM McGladrey.

Education: B.S. in Accounting, B.S. in Business Admin., Illinois State University, summa cum laude, 1983. Tim received numerous honors at ISU, including Bone Scholar, the highest undergraduate designation awarded and the Raymond Esworthy Award for outstanding accounting student. He was initiated into the Beta Gamma Sigma Honor Society.

Henry Huang

Investment Director, TDK Ventures

Investment Director, TDK Ventures

Henry Huang is an Investment Director with TDK Ventures, covering computing, connectivity, industrial and mobility.

Prior to joining TDK Ventures, he had extensive experience in the telecommunication industry, including various roles with AT&T, NextG Networks (acquired by Crown Castle), Tarana Wireless, 3TEN8, and TTS Wireless (acquired by AMDOC). His responsibilities covered R&D, engineering, product management, customer success, technical sales, marketing, and investment.

He holds a Ph.D. degree from the University of Missouri-Columbia, a Bachelor of Science degree from the University of Science and Technology of China (USTC), both in Electrical Engineering and an MBA degree from The Wharton School of the University of Pennsylvania.

In his free time, he loves to travel around the world with his wife and three children. He has backpacked in Tibet, hiked in Peru, and ran a marathon in Switzerland.

Kanaan Jemili, PhD

Co-Founder & CEO, Visaic

Co-Founder & CEO, Visaic

Experienced Chief Executive Officer with a demonstrated history in leading cross functional organizations to achieve healthy growth and margins. Strong entrepreneurship professional, skilled in Sports Technology, Streaming, AI based Fan engagement, Product Lifecycle Management, Video Technologies and Services, Go-to-market Strategy, Sales and Marketing, M&A, Private and Public Corporate Management.

Prashant Kantak

Mentor, Former Founder, Qualcomm Ventures

Former Founder, Qualcomm Ventures

Prashant Kantak is an early-stage venture advisor and investor. He plays an active role in helping determine business and product strategy, organization and go-to-market strategy and takes operational roles as needed in early stage companies. He started and led Qualcomm Ventures, a $500M strategic venture capital fund of Qualcomm, and built operations in North America, Europe and Asia including Korea ($60M), Japan ($30M) and China ($100M) for 6 years from 1999 through 2005. He led investments in and actively managed over 24 portfolio companies in the US and several more worldwide, many of which were either acquired or taken public, including Paypal (acquired by EBAY), Air Prime (acquired by SWIR), GTRAN Wireless (acquired by FLEX), PacketVideo, Iridigm (acquired by QCOM), Airvana (IPO), Discera and JAMDAT (IPO). He led the creation of strategic alliances, co-development and business partnerships between startup companies and Qualcomm operating units. This activity resulted in expanding markets for and augmenting Qualcomm’s existing products and services as well as driving innovations through enabling new technologies and business models internally and in the industry. He was on the steering committee to formulate and drive Qualcomm’s internal innovation efforts. He was also responsible for various corporate development efforts including technology and business strategy, strategic alliances, partnerships and mergers and acquisitions.

Prashant has over 20 years of business and technical experience in the field of telecommunications. He was with Qualcomm since early 1990 and held various technical and business management positions within Qualcomm. He participated in the early definition and development of CDMA standards and systems and thereafter developed key ASICs for their implementations both on the infrastructure and mobile side. He also designed and implemented innovative DSP architectures for mobile communications that form the core platform for Qualcomm’s commercial ASICs. Prashant has an MBA from Cornell University. He also has a MS and BS in Electrical Engineering.

He is also actively involved in various initiatives to help foster the entrepreneurial community in the telecom sector. He served on the Board of San Diego Software Industry Council and currently serves on the advisory board of EvoNexus and is on the selection committee of the local incubator, EvoNexus, since its founding.

Pankaj Kedia

Founder & Managing Partner, 2468 Ventures

Founder & Managing Partner, 2468 Ventures / former Senior Executive, Qualcomm & Intel

Pankaj Kedia is a Tech Intrapreneur (formerly at QCOM and Intel) turned Early-Stage AI / Deep Tech Investor, Venture Partner, CXO Advisor and Board Member.

Pankaj currently serves as the Founder and Managing Partner of 2468 Ventures, a Venture Partner at VU Ventures, a Deal Partner at Ganas Ventures, and is a Board Member and CEO Advisor to numerous early-stage start-ups and non-profit organizations.

As a Tech Intrapreneur, Pankaj played pivotal roles in incubating a range of businesses at Fortune 100 companies such as Qualcomm and Intel over the last 25+ years. At Qualcomm, Pankaj founded and led the wearables business to a 9-figure franchise, establishing Snapdragon Wear as the premier brand in the industry. Credited for leading industry convergence between wearable tech and fashion, luxury, sports, children, seniors, and enterprise segments, Pankaj established a thriving ecosystem in the wearables segment. Previously at Intel, Pankaj held senior executive roles in the PC, mobile, wireless, and handheld segments. He defined and launched the industry's first modern laptops and expanded Intel beyond the PC with the launch of the industry's first modern tablets, handhelds, and smartphones.

Pankaj is currently leveraging the skills he acquired as an intrapreneur -- being able to see around corners, go from ideas to products, scale businesses from $1M to $100s of millions (and billions in the case of laptops), and grow teams and organizations -- to advise Early-Stage Founders and CEOs in their start-up growth journey. As an angel investor in 100+ Early-Stage and Series A companies, Pankaj is combining his passion for AI and Deep Tech with his ambition to make a long-lasting impact. Previously, Pankaj led business development for the wireless portfolio at Intel Capital, which was comprised of 30 start-ups with $75M invested capital.

Pankaj is widely recognized as a thought leader in the mobile, IOT, wearables and AI spaces, has spoken at multiple prominent industry events, and appeared in a myriad of mainstream publications. He holds the early defining patent on low power for mobile devices (#7725748, Low Power Subsystem for Portable Computers).

Pankaj is currently enrolled in the Stanford LEAD innovation program, has an MBA from The Wharton School, an MS from the University of Michigan, a BS from the Indian Institute of Technology and has taken multiple management, leadership, and investing courses at Stanford, Columbia, and Darden in his quest for life-long learning. He is a TED speaker, amateur photographer, global traveler, and a gadget addict.

Dong-Su Kim, Ph.D.

CEO & Board Member, Corporate EVP, LG Technology Ventures

CEO & Board Member, Corporate EVP, LG Technology Ventures

Dong-Su Kim is the CEO and board member of LG Technology Ventures. He has over twenty-five years of investment, strategy, planning, and technology experience. As the founding CEO, Dong-Su established the fund structure, hired key people, and initiated investment operations. Under his guidance, LG Technology Ventures manages over $400 million of fund assets and invests in early-stage information technology, automotive, manufacturing, life-sciences, energy, and advanced materials companies. Portfolio companies include AmazeVR, Lygos, May Mobility, and Ridecell. Dong-Su Kim was also recently promoted to corporate Executive Vice President.

Previously, Dong-Su was Vice President and GM of Samsung Ventures America where he managed offices in Menlo Park, Boston, London, and Tel Aviv. He has led the investment of over thirty companies in diverse sectors including semiconductors (Soft Machines, Verisilicon, Wave Computing), equipment (DCG Systems, IMS, Reno Subsystems), materials (Nanosys, NexPlanar, Voltaix), and storage systems (Pure Storage).

Prior to joining Samsung Ventures, he was a Director at Asia Evolution, an investment bank in Korea covering mid-market financing, private placement, and M&As.

Before that, he was a Director at the Technology Strategy Office of Samsung Electronics. As the CTO’s staff, he was responsible for strategic venture investments and technology alliances. He also worked in technology planning for Samsung’s Telecom R&D center, responsible for discovering new research topics. Dong-Su started his professional career as a Technical Leader at Samsung Fiber Optics Business Unit in development of fiber optic components.

His past Board Director appointments include Datera, Digital Specialty Chemicals, Femtometrix, Inpria, Reno Subsystems, SBA Materials, SVXR, D2S, DCG Systems (acquired by FEI), NexPlanar (acquired by Cabot), Voltaix (acquired by Air Liquide), Panasas, and Pixtronix (acquired by Qualcomm). Dong-Su also served on the Investment Advisory Committee for Sierra Ventures.

Dong-Su has earned an M.A. and a Ph.D. in Electrical Engineering from Princeton University, and a B.S. with Honors in Applied Physics from California Institute of Technology.

Ashok Kamal

Executive Director, NuFund

Executive Director, NuFund Venture Group

Ashok Kamal is an Executive Director & Co-Fund Manager of NuFund Venture Group, a San Diego-based early-stage investment fund created by, and formerly known as, Tech Coast Angels - San Diego. NuFund is one of the largest, most active and most successful early-stage investor groups over the past 20+ years. They invest primarily in tech and life sciences.

As a social entrepreneur, Ashok is driven to attack our biggest global challenges, such as education, environmental degradation and health & wellness. He values creativity, tenacity and resourcefulness and wants to connect with people who have a vision for a better world, and share his mission for being part of the solution and making things happen.

Ashok has diverse experience starting, leading and investing in organizations in the private, public and nonprofit sectors. His entrepreneurial path includes bootstrapping to profitability, winning award money in the world's most prestigious business plan competition and raising money from an accelerator and venture capitalists, and angel investing in technology startups. As a speaker and presenter, Ashok is grateful to have been given the opportunity to share at various events, including South By Southwest, Sustainable Brands, GreenBiz Forum, LAUNCH Festival, Gamification Summit and the White House's GreenGov Symposium. In addition, he's contributed numerous articles and interviews to technology and business websites such as VentureBeat, Forbes and Fast Company.

Carlos Kokron

VP & Managing Director, Qualcomm Ventures

Vice President and Managing Director, Qualcomm Ventures

Carlos Kokron is the Vice President and Managing Director of North America, based in San Diego, CA. He is currently Board member or observer at Augury, Matterport, Spire, Particle, CargoX, Loggi, Ingresse, and WebRadar.

He started his career as an engineer in process industries having held positions in operations and process engineering, as well as strategic planning and corporate finance at Unilever in Brazil and at Unocal 76 (now Chevron) in California. Prior to joining Qualcomm Ventures he was responsible for Intel’s business with Service Providers in Latin America. Earlier, Kokron was Director of Intel Capital for Latin America and Southwest U.S. and Partner at Stratus Group in Brazil responsible for the firm’s Growth Capital platform. Kokron holds B.S. and M.S. degrees in Chemical Engineering and has earned his MBA from the Haas School of Business at U.C. Berkeley.

Masashi “Mac” Kubota

Corporate Venturing Manager (CTO function), Murata

Corporate Venturing Manager (CTO function), Murata

Masashi "Mac" Kubota is currently a Manager at Murata, meaning he is responsible for Corporate venturing & CTO function. Mac is passionate toward contributing to the advancement of society and being an innovator in electronics, sympathized with Murata's philosophy and slogan. He is bringing experience from previous roles at Nomura-SRI Innovation Center (NSIC), Murata, RIKEN and ROHM Co., Ltd.. Mac Kubota holds a 2014 - 2014 Ph.D. in Engineering in Frontier Materials Science, Department of Applied Physics @ The University of Tokyo. With a robust skill set that includes Development, Semiconductors, Optics, Business Development, Technology and more, Masashi Kubota contributes valuable insights to the industry.

Dr. Quinn Li

SVP & Global Head, Qualcomm Ventures

SVP & Global Head, Qualcomm Ventures

Quinn oversees Qualcomm’s $1B global venture investment portfolio of 150+ companies across seven global regions. Quinn and his team invest in key areas such as 5G, AI, Automotive, IoT and Networking to help expand Qualcomm’s ecosystem of customers and partners. He currently serves as a board member or observer in Airspan, ClearMotion, Cohesity, Innovium, Pensando and RetailNext. Quinn has led over a dozen investments with successful exits in A123 Systems, Eero, InvenSense, Powercloud Systems and Zoom.

Quinn started his career as an engineer working on 3G wireless technology and standards development at Lucent Technologies. Prior to joining Qualcomm Ventures, he worked in product management and business development in IBM Systems and Technology Group. Earlier, he worked on wireless technology development at Broadcom.

Quinn received his MBA from Cornell University, and his B.S., M.S. and Ph.D. in Electrical Engineering from Washington University in St. Louis.

Howard Mirowitz

Manager, Cove Fund II

Manager, Cove Fund II

Howard Mirowitz has over 30 years of experience in formulating and executing growth strategies and leading new product development. During his career, Howard co-managed Mitsubishi Electric’s U.S. high-tech business incubator, which created the first Web-capable smart phone, PocketNet, which AT&T Wireless launched at the Super Bowl. The incubator also seed-funded OpenWave, which had a successful IPO, and made profitable investments in other key smart phone-related technologies. Prior to this, Howard led advanced product planning and product marketing in Mitsubishi’s U.S. Computer Division, where he launched several new products that achieved leading U.S. market shares and started a U.S. personal computer factory. At Western Digital, Howard engineered the acquisition of Paradise Systems, which subsequently achieved the #1 share of the worldwide personal computer display controller market. Earlier, Howard headed market research and planning at Microdata Corporation and led Deloitte & Touche’s Philadelphia IT consulting practice.

Howard is very active in community and charitable causes in Orange County, he was named as Jewish Federation and Family Services’ Mensch of the Year and honored with OneOC’s Volunteer of the Year award. He has served as Co-Chair of the Orange County Transportation Authority’s Measure M Taxpayers’ Oversight Committee and as Co-Chair of the Newport-Mesa Unified School District’s Measure A Community Oversight Committee; he is past Board Chair of the Mental Health Association of Orange County and he has been a Board Advisor to the Illumination Foundation since its inception.

Howard received his BA from Dartmouth College and his MBA from the Wharton School of the University of Pennsylvania. He has taught New Product Development at UCI’s Merage Business School and currently teaches occasional courses at UCI Extension’s Osher Lifelong Learning Institute. He is a member of the Advisory Board of UCI’s Beall Center for Innovation and Entrepreneurship and currently serves as an Expert-in-Residence at UCI Applied Innovation. He is also a partner in the Cove Fund and serves on the Fund’s Investment Committee.

Oliver Mitchell

Venture Partner, ff Venture Capital

Venture Partner, ff Venture Capital

Oliver Mitchell is a Venture Partner at ff Venture Capital, a New York based firm with 90+ portfolio companies and $200 million under management. He is also the founding partner at Autonomy Ventures, a venture syndicate focused on early stage investments in business and industrial automation technologies, including robotics, smart mobility, remote sensing and artificial intelligence. Oliver’s investment portfolio has returned over six exits in the past five years with two IPOs and one unicorn presently valued over $11 billion. Previous transactions have included selling Holmes Protection to ADT/Tyco, Americash to American Express, and launching RobotGalaxy, a national consumer brand. He is a mentor at NYU Stern’s Endless Frontier Labs and holds 14 patents. Oliver speaks often at international trade shows and writes trade periodicals that reach thousands of readers.

Robert Mittendorff, M.D.

General Partner & Head of Healthcare, B Capital Group

General Partner & Head of Healthcare, B Capital Group

Dr. Mittendorff is a General Partner and Head of Healthcare who leads investments at B Capital in venture and growth opportunities in the sector. Previously, he was at Norwest Venture Partners for nearly a decade as Partner and Co-Head of Healthcare. He has been involved in investments and associated exits with public equity value or acquisition value that exceed a total of $10B. He is a board certified emergency physician and former public company operating executive with experience that spans investing, complex business development transactions, the leadership of clinical advisory boards, product development, clinical trials, commercial activities, and clinical services management. He is a Fellow of the American Academy of Emergency Medicine (FAAEM).

At B Capital, he focuses on investing in category defining companies in healthcare led by exceptional leadership teams.

He has served on the boards of Impel Neuropharma, Avalyn Pharma, Qventus, and VisitPay, TigerConnect, Neocis, and was a board observer at Talkspace, Omada, and Route92. He was a board member at Silk Road Medical (SILK), iCardiac (acq. by eResearch), and Telcare (acq. by BioTelemetry). He was a previous board observer at Intersect ENT (Nasdaq: XENT), and iRhythm Technologies (Nasdaq: IRTC). Dr. Mittendorff was involved with the initial investments in Misfit Wearables (acq. by Fossil) and Health Catalyst (HCAT). He also led seed investments in Myome, Excision Biosciences, and Clerio.

Dr. Mittendorff was co-chair of the Digital Healthcare Innovation Summit and was a member of the Leadership Fellows at Johns Hopkins.

Prior to his career in venture capital, Dr. Mittendorff was an executive officer and the Vice President of Marketing and Business Development at Hansen Medical Inc. (Nasdaq: HNSN, acquired by Auris/JNJ). He launched multiple products including the Magellan & Sensei X robots and led the Company’s partnerships with GE, Siemens, Philips and St. Jude Medical In transactions above $100M. He created the SAB and pitched in a $30M public financing.

Dr. Mittendorff has also worked in portfolio strategy at Merck and as a management consultant at BCG, and at Kaiser Permanente as an emergency physician. He earned a Harvard M.D., trained at Stanford in Emergency Medicine, and received his M.B.A from Harvard Business School and his B.S. in biomedical engineering from Johns Hopkins (high hon) where he was a varsity athlete. He has completed fellowships with Howard Hughes, MIT and HBS. He is an avid Premier League fan (Manchester United).

Zachary Myers

Partner, Wilson Sonsini Goodrich & Rosati

Partner, Wilson Sonsini Goodrich & Rosati

Zach Myers is a partner at Wilson Sonsini Goodrich & Rosati where he specializes in corporate and securities law, including mergers and acquisitions, venture capital financings, and general corporate representation. He represents private and public companies in the technology and life sciences sectors—especially biotechnology and medical device companies—in complex, high-value transactions.  He has represented a number of leading companies in venture capital financings, helping them raise millions of dollars needed to fund, grow, and expand their businesses. He has also assisted numerous clients that have gone public, listing on the New York Stock Exchange and NASDAQ markets.

Nandhu Nandhakumar

CTO, Alat, Former SVP, Office of the CTO, LG Electronics

CTO, Alat; Former SVP, Office of the CTO, LG Electronics

As the Chief Technology Officer at Alat – a transformative company backed by $100B of capital by Public Investment Fund (PIF) - Nandhu Nandhakumar leads innovation and technology strategy across our various business units comprising Smart Devices, Smart Appliances, Smart Health, Smart Buildings, Advanced Industrials, Next Gen Infrastructure, and Semiconductors.

He believes strongly in the value of cross-industry collaboration to make meaningful and impactful technology contributions. I lead partnerships with technology innovators (startups, VCs, university labs, etc.), and have founded and serve in leadership positions of various industry consortia and global technology standards development organizations.

Previously, at LG Electronics, Nandhu led initiatives in digital media, robotics, and AI. As the founding head of LG’s Technology Center of America, he established the North American Corporate Venture Capital effort, investments in startups, and collaborations with university research labs.

As member of University Faculty, Nandhu has taught graduate and undergraduate courses, and performed funded (PhD and post-doctoral) research in computer vision, AI, robotics, & video processing - funded by NASA, DARPA, NSF, USAF, etc.

Michael Nowak, PhD

Managing Partner, Nowak Ventures

Managing Partner, Nowak Ventures, LLC

Dr. Michael J. Nowak is an experienced healthcare and high-tech institutional investor in small cap public and venture-backed private companies, serial entrepreneur, and licensed investment banker. Michael has most recently served as advisor to a leading early-stage venture capital fund and their portfolio companies, two leading universities on their innovation and commercialization efforts, industry-leading corporations, and California Life Sciences Assoc. FAST program companies. Previously he was CEO and President of a Stanford University spinout and JLABs company focused on non-viral transfection technology for cell and gene therapies where he closed a significant seed round of financing from institutional and corporate VC investors. He is Managing Partner of his own consulting and advisory firm and is Managing Director at BJC Capital, an independent boutique investment bank.

In the past Michael was a Managing Director and Head of Healthcare Investments for Yorkville Advisors, $B+ AUM multinational hedge fund. Before that he led investments and served on numerous Boards of Directors while a General Partner at leading $B Euro-US venture capital fund TVM Capital. He was also a corporate venture capitalist and business development executive at Xerox PARC and Xerox Venture Labs in Palo Alto, where he was CEO of two spinouts. Furthermore, he was a strategic management consultant and Vice President at McKinsey & Co. in an emerging technology practice, and a Program Manager at the Advanced Technology Program, National Institute of Standards and Technology, US Department of Commerce. At NIST he managed two $100M+ investment programs in software and digital media technology.

Dr. Nowak earned an MBA from the Wharton School at the University of Pennsylvania and a PhD in Physics from the University of California, Santa Barbara. He worked as a post-doctoral scientist at Bell Labs (Bellcore), Princeton University, and at the CEA research labs in Saclay and the University of Paris VI (Jussieu, now Sorbonne University), in Paris, France. He received his BA in Physics from Cornell University in Ithaca, NY, where he was a College Scholar.

Kenneth Rollins

Partner, Cooley LLP

Partner, Cooley LLP

Mr. Rollins has a general corporate transactional practice, representing emerging and late stage private companies and public companies in a wide range of corporate and securities matters, including private financings, public offerings, mergers and acquisitions, tender offers, strategic collaborations, commercial agreements, corporate governance matters, and employment and compensation arrangements. He also advises venture capital firms in connection with financings and other transactions.

Mr. Rollins is counsel to companies in diverse industries, including information technology, biotechnology, medical device, retail, semiconductor, software and cleantech. His clients range from start-ups to public companies with hundreds of millions of dollars in annual revenues.

J.C. Ruffalo

Venture Partner, Cove Fund

Venture Partner, Cove Fund

J.C. (Jeffrey Charles) Ruffalo recently joined Cove Fund as a Venture Partner. Prior to joining Cove Fund, J.C. was the Director of LaunchPad and Investor Relations at Octane OC, a top 5 of over 900 SBA funded incubators in the US. During his Octane tenure, J.C. advised and assisted over 300 companies in a wide range of innovative technology industries successfully attain strategic goals. These companies raised over $2 billion in capital and realized over $2.6 billion in M&A. Of the more than 10,000 high paying technology jobs created, 85% were in Southern California. These companies include Hyperice, Bonti, EV Connect, AtaCor Medical and Enevate.

J.C. believes that nurturing and maintaining strong relationships between entrepreneurs, innovators, and investors is key in successful venture partnerships. J.C. received a BS in in Entrepreneurship and Finance, and a minor in Economics from Chapman University Argyros School of Business.

Brad Schoening

Executive Director, JPMorgan Chase & Co.

Executive Director, JPMorgan Chase & Co.

Brad is a senior strategic leader in big data and data privacy. His diverse experience includes working with Wall Street fintech in New York, as well as startup companies in Silicon Valley and London.

Throughout his career, he has held a variety of leadership positions in engineering management, strategic consulting, sales engineering and professional services at companies such as Morgan Stanley, Cisco Systems, DataStax and Privitar. Brad holds six patents from his work at Cisco.

He is an open-source author and has created a format-preserving encryption library, Mysto, which makes privacy-enhancing technology more accessible to businesses and users. Mysto enables software developers to de-identify personal information within their database, in compliance with national encryption standards.

Brad has a B.A. in physics and mathematics from Drew University, and a Master’s degree in Computer Science from the University of Illinois Urbana-Champaign. In addition, he is a PMI Agile Certified Practitioner (PMI-ACP).

Ben Strom

Venture Partner, Impact Venture Capital

Venture Partner, Impact Venture Capital

Ben S. is an experienced advisor, venture partner, and real estate principal who has worked with various companies in different roles such as real estate investor, operator, JV partner, investment committee member, board advisor, equity analyst, portfolio manager, partner, senior analyst, and sector head. Ben's experience includes working in early-stage venture capital funds, managing long/short equity funds, and overseeing real estate developments. Ben also has a background in finance from the University of F and has attended Harvard University and the Haarlem School of Business for further education.

Hem Suri

EvoNexus Fintech Executive In Residence, Founder & Managing Partner, Spark Growth Ventures

Founder & Managing Partner, Spark Growth Ventures / EvoNexus Fintech Executive in Residence

Hem is an accomplished investment, board and executive management leader with two decades of experience as an entrepreneur, venture capitalist, board professional, investment banker, general management executive as well as a researcher.

Hem currently serves as the Founder & Managing Partner of Spark Growth Ventures, an early-stage technology venture capital firm with a Pan American focus. Previously, he was the Co-Founder and Managing Partner of ClearVision Equity, a 2x Interim CEO of emerging healthcare companies, an executive of a KKR Private Equity portfolio company, an investment banker on Wall Street as well as a functional leader in multiple Fortune 500 companies in the US.

Hem has also served on over 20 startup and social enterprise boards across US and is heavily involved with several prominent incubators and accelerators in SoCal supporting budding entrepreneurs. He has executed 40+ venture, private equity and M&A transactions with over $2B in total capital spanning over 12 years at Spark Growth Ventures, ClearVision Equity Partners, Deutsche Bank, and a KKR private equity portfolio company.

Hem has an M.B.A. from Harvard, an M.S. from University of Illinois and a B.Tech. from Indian Institute of Technology, New Delhi. He is passionate about the environment, equality and education for under-privileged children, and loves reading, traveling and active pursuits.

Richard Tapalaga

Partner, Qualcomm Ventures

Partner, Qualcomm Ventures

Richard is a Director at Qualcomm Ventures. His investments focus around augmented/virtual reality, Internet of Things (IoT), mobile applications and connected device ecosystems. Richard joined Qualcomm Ventures in 2008 and serves as a Board Member/Board Observer for investments in Airspace Technologies, Brain Corporation, Embee Mobile, Magic Leap, Realwear, ThatGameCompany and other strategic investmentS. Former investments (exits) include HeyZap (acquired by RNTS Media), Livescribe (acquired by Anoto), Owlchemy Labs (acquired by Google) and Earn.com (acquired by Coinbase).

Prior to joining Qualcomm, Richard had over seven years of investment banking experience at Merrill Lynch & Co and Société Générale. As a Vice President at Société Générale, Richard led the leveraged finance deal teams in the Gaming, Lodging, Leisure and Media & Telecom sectors.

Richard holds an MBA from Cornell University’s Johnson School of Business and a B.S. from New York University’s Stern School of Business.

Andy Taylor

Mentor, Former VP & GM, Home New Ventures, Credit Karma

Former VP & GM, Home & New Ventures, Credit Karma

Andy Taylor is the former VP & General Manager of Credit Karma Home & New Ventures, which he joined through the acquisition of Approved, a mortgage technology company he founded in 2015 and incubated at Evo Nexus. Day to day, he’s on a quest to improve the usually frustrating mortgage experience and help consumers get closer to the American Dream of homeownership. Prior to Approved, Andy ran the product team at Redfin, where he really got to know today’s home buyers and sellers. Before that, he worked as a Product Marketing Manager at Apple in Photo Products, and in a former life, he programmed video games as a software engineer at Electronic Arts. He holds a degree in Computer Science from Stanford and got his MBA from the Haas School of Business at UC Berkeley.

Dr. Paul Voois

Managing Partner, Cove Fund

Managing Partner, Cove Fund; Former CEO, ClariPhy

Dr. Paul Voois is an entrepreneur and early stage investor with a track record of building valuable companies with unique, defensible technology in the networking, communications and software industries. In 2002 he co-founded ClariPhy Communications, a venture-backed supplier of optical networking semiconductors that was acquired by Inphi (NYSE:IPHI) in 2016. He served as ClariPhy’s CEO until 2011 and as Chief Strategy Officer until its acquisition. Prior to founding ClariPhy, he served as CEO of 8×8 (NASDAQ:EGHT), a market leader in voice and video over IP technology. Dr. Voois received an M.S. and Ph.D. from Stanford and a B.S. (summa cum laude) from Penn State, all in electrical engineering. He is an inventor on 24 issued United States patents.

Dr. Voois is an active early stage investor. He resides in Orange County, CA and is a member of Tech Coast Angels and a manager of the Cove II Fund.

Albert Wang

Senior Investment Director, Qualcomm Ventures

Senior Investment Director, Qualcomm Ventures

 Albert Wang is a Senior Director at Qualcomm Ventures. His investment focus areas are mobile/5G, cloud, internet of things (IoT), artificial intelligence (AI), and Web3. Albert led the investments and serves as a board observer for Uhnder, Plume, SiFive, Oosto, AttackIQ, Clarifai, BlueStacks, Workspot, Mountain Digital and Avalanche. Previously, Albert led the team’s investments in FreedomFi (acquired by Nova Labs), Ring (acquired by Amazon), Cavendish Kinetics (acquired by Qorvo), Bracket Computing (acquired by VMware), CurbSide (acquired by Rakuten), Ineda (acquired by Intel), MapR (acquired by HPE), PLUMgrid (acquired by VMware), and Gaikai (acquired by SONY). Albert helped launch the Qualcomm AI Fund in 2018 and currently manages the Qualcomm 5G Fund.

Prior to Qualcomm Ventures, Albert worked in various engineering and management roles in the wireless industry. Most recently, he worked at Lux Capital focusing on MEMS and nanotechnology startups. He also spent a few years at Skyworks Solutions and managed the product development of several wireless chips that power the most popular smart-phones today. Albert received his MBA from the UCLA Anderson School of Management, his Ph.D. in Electrical Engineering from the University of Cincinnati, and his B.Sc. in Electrical Engineering from Zhejiang University.

Albert lives in San Diego and enjoys the outdoors with his wife and twin boys, hiking, biking, swimming, skiing, sailing and coaching the boys on tennis.

Gene Dantsker, Ph.D., MBA

Gene Dantsker, Ph.D., MBA

EvoNexus Executive Advisor, Former Sr. Director of Business Development & Licensing, Qualcomm
Kathy Ouellette

Kathy Ouellette

EvoNexus Vice Chairman, CEO & President, Perma Pure
Alex Arrow, M.D.

Alex Arrow, M.D.

CFO, Strateos, Inc.
Matt Borer

Matt Borer

Associate Director, Corporate Strategy and Business Development, BD Biosciences
John Buhler

John Buhler

Member Board Of Directors, Mopec
Ross Bundy

Ross Bundy

CEO, CRISPR QC
Niall Casey, JD

Niall Casey, JD

Co-Founder & CTO, Carlsmed
Mike Cordonnier

Mike Cordonnier

CEO & Co-Founder, Carlsmed
John DeNuzzio Ph.D.

John DeNuzzio Ph.D.

Principal, DeNuzzio MedTech Consulting
Rob Douglas

Rob Douglas

Advisor, ResMed Inc.
Dr. Rakhi Garg

Dr. Rakhi Garg

Product Management - Sleep & Respiratory Care, Philips Healthcare
Jason Halac

Jason Halac

Senior Director, Dexcom Ventures
Michael J. Hennessy, M.D.

Michael J. Hennessy, M.D.

Independent Medical Practice Professional
Dr. Michael Hill

Dr. Michael Hill

Global Head, Science, Technology, and Innovation, Science Innovations, LLC
Kelly Ko, PhD

Kelly Ko, PhD

VP Innovation & Strategic Initiatives, Sharp HealthCare
Dr. Richard Kurtz

Dr. Richard Kurtz

VP Corporate Business Development, Bio-Rad
Ryan Lakin

Ryan Lakin

Divisional VP, R&D, Abbott
Gregg Landis, M.D.

Gregg Landis, M.D.

System Chief of Vascular Surgery, Northwell Health
Dr. Thomas Lawrie

Dr. Thomas Lawrie

CMO, Sharp Memorial Hospital
John “Rick” LeMoine, MD

John “Rick” LeMoine, MD

CMIO, Sharp HealthCare
Giovanni Magni

Giovanni Magni

Mentor, Former EVP & Chief Strategy Officer, Bio-Rad
Zachary Myers

Zachary Myers

Partner, Wilson Sonsini Goodrich & Rosati
Nandhu Nandhakumar

Nandhu Nandhakumar

CTO, Alat, Former SVP, Office of the CTO, LG Electronics
Michael Nowak, PhD

Michael Nowak, PhD

Managing Partner, Nowak Ventures
Carlos Nunez, M.D.

Carlos Nunez, M.D.

CMO, ResMed
Mike Perry

Mike Perry

Executive Chairman, Avive Solutions
Malcolm Pond, MD

Malcolm Pond, MD

Licensed Cardiologist
Dr. Karthik Ranganthan

Dr. Karthik Ranganthan

WW VP, Alaris Business Leader, BD
Hemanth Reddy

Hemanth Reddy

CSO, ResMed Inc.
Howard Robin, MD

Howard Robin, MD

President & CEO, LJ Pathology Consultants, Inc.
Dereck Tatman, PhD, MBA

Dereck Tatman, PhD, MBA

Founder, President, & CEO, Intrigue Health
Pieter van Rooyen

Pieter van Rooyen

CEO, President, & Founder, Pleno
Dr. Josh Windmiller

Dr. Josh Windmiller

Head of New Analytes & Sensing Platforms, Dexcom

Gene Dantsker, Ph.D., MBA

EvoNexus Executive Advisor, Former Sr. Director of Business Development & Licensing, Qualcomm

EvoNexus Executive Advisor

Dr. Gene Dantsker is the former President and Chief Operating Officer and current Executive Advisor of EvoNexus. He has been involved with EvoNexus since its founding as selection committee member, mentor to numerous portfolio companies, Executive-in-Residence and most recently Chief MedTech Officer. Gene is a seasoned entrepreneur, board member, advisor, operational executive and angel investor.

Prior to the EvoNexus role, Gene worked across the spectrum of technology solutions in semiconductor, IT, medical and biotech businesses. His career path brought together engineering, science, business and entrepreneurship.

Following graduate school, Gene was Senior Technical Staff Member at TRW, Inc., Space and Electronics Division (now part of Northrop Grumman) where he was responsible for design, fabrication, and integration of microelectronics for space/satellite applications. Subsequently he co-founded Nanostream, Inc., a biotechnology company and provider of high-throughput bio-analytical instruments to companies involved in drug discovery and development. As VP of Technology, Dr. Dantsker was co-inventor and developer of Nanostream’s core technologies based on polymer MEMS microfluidics and converted them into commercial products purchased by leading pharmaceutical companies. Gene then served as CEO and CTO of aDNAvance Technologies, Inc., a provider of ultra-sensitive medical molecular diagnostic products, operating out of the US and Canada. Gene also served on the Board of Directors of D-Wave Systems, a pioneer in Quantum Computing, with leading Silicon Valley VCs, as well as heavily consulted the company in business development, IP strategy, growth strategy and operational infrastructure. Gene subsequently headed business development for the US branch of Nitto Denko, a leading supplier of diversified polymer-film products for medical, electronic and optronic applications, based in Osaka, Japan.

Gene then joined Qualcomm Life as Sr. Director of Business Development & Licensing, where his responsibilities included enabling intelligent integrated care models through the Internet of Things (IoT) in the pharmaceutical, medical device, diagnostics and payer industries. In 2020, he helped sell the original Qualcomm Life business, to Philips before moving on. Following the sale, Gene joined Amazon Web Services as Global Lead for Medical Devices.

Gene holds B.S. degrees in Physics and Mathematics from the University of Maryland, M.A. and Ph.D. in Physics from the University of California at Berkeley, and an MBA from San Diego State University, where he was class valedictorian. He is an inventor on over 60 issued patents.

Kathy Ouellette

EvoNexus Vice Chairman, CEO & President, Perma Pure

EvoNexus Vice Chairman // CEO & President, Perma Pure/Maxtec

As a global business leader, Kathy Ouellette's area of expertise is delivering differentiation and value through strategy, process, and product innovation.

Her career consists of commercial and operational roles at Thermo Fisher Scientific, Illumina, and several startups. She previously served as General Manager for a global Thermo Fisher business unit.

Wide-ranging leadership of “blank slate” and turnaround initiatives has been a constant theme of her career. Kathy's experience includes marketing, sales, R&D, manufacturing, and distribution functions, including leading global cross-functional teams. From strategy to execution, she has operations experience in North and South America, EMEA, and Asia-Pacific countries.

Engaging teams to perform their best work is another strength. Kathy thrives in corporate cultures where innovation and integrity are valued, and she represents those values in her customer and company relationships.

Alex Arrow, M.D.

CFO, Strateos, Inc.

Chief Financial Officer, Strateos, Inc.

Alex is a MedTech finance executive and former equity analyst. He led equity research for Lazard Capital Markets and Wedbush Morgan, and held operating roles at private and public companies, including Biolase, Circuit Therapeutics, and Arstasis. Alex currently serves as a Board Member at Zelegent, Paragonix Technologies, and 8i Acquisition Corp and previously served on the boards of Medcura, Neumedicines, and Biolase. Alex has an M.D. from Harvard Medical School, a B.A. in Biophysics from Cornell University, and is a CFA charter holder.

Matt Borer

Associate Director, Corporate Strategy and Business Development, BD Biosciences

Associate Director, Corporate Strategy and Business Development, Becton Dickinson (BD) Biosciences

Matt Borer is an Associate Director, Corporate Strategy and Business Development leader at BD Biosciences and has more than 20 years of medical technology experience. In his role, Matt is responsible for leading opportunity assessments and commercial due diligence for new technology initiatives. Prior to joining BD Biosciences, Matt was the Senior Director of Marketing at ResMed, a leading provider of respiratory technologies and the global leader in remote monitoring.

Prior to this role, Matt held many positions of increasing responsibility within the medical device industry focusing on identifying and incubating market leading solutions for hospitals, physician offices and home care providers.

Matt holds a Bachelors Degree in Economics from the University of California, Irvine and an MBA from the University of Southern California.

John Buhler

Member Board Of Directors, Mopec

Member Board Of Directors, Mopec

Mr. Buhler holds extensive healthcare industry and business leadership expertise stemming from a 33-year career with RF Surgical Systems, Inc., Natus Medical Inc., SenoRx Inc., Ultrasonix, GE Healthcare and Diasonics-VingMed Ultrasound. Mr. Buhler has a proven track record of building and leading successful world–class business teams that consistently achieve strong financial performance, operational efficiency and customer loyalty.

Mr. Buhler earned his B.S. degrees in Business Administration and Human Resources at Dominican College, Blauvelt, New York as well a degree in Electrical Technology from the State University of New York at Orange County. Mr. Buhler has also completed the Executive Management Development Program (EMBA equivalent) at General Electric’s Educational Center in Crotonville, New York.

Mr. Buhler’s extensive experience in the healthcare field spans 30+ years. He has been the CEO/COO of three public and two private companies, completed numerous rounds of financing, done ~$1bb in M&A, and recently merged RF Surgical Systems, Inc. with Medtronic. He has successfully completed four turnarounds, each entity becoming a high growth/profitable business in its discipline.

Mr. Buhler has an impressive history generating new revenue streams, building business, and increasing market share for multi-million and multi-billion dollar international high-technology corporations. His businesses have demonstrated the ability to penetrate new markets and strengthen competitive positioning, design and direct high-impact strategic plans, define visions and transform concepts into lucrative workable realities.

Mr. Buhler is now Chairman Of The Board of OmniGuide Holdings: advanced surgical technology engineered to deliver an optimized surgical experience and superior patient outcomes.

Ross Bundy

CEO, CRISPR QC

CEO, CRISPR QC / Co-Founder & Chief Entrepreneur, Cardea Bio Inc.

Ross Bundy, Co-founder of Cardea Bio, brings his vision for directing strategy, operations, and planning to the company’s market-leading technology solutions at CRISPR QC.

Ross is responsible for new expansions and key projects at Cardea including scaling up the chip production for Cardea and help setting up partnerships. With an MBA from San Diego State University, Ross has held positions in supply chain, operations, and finance from companies such as General Dynamics and UBC Financial Services. Ross brings precision execution and implementation to the company.

Niall Casey, JD

Co-Founder & CTO, Carlsmed

Co-Founder & CTO, Carlsmed

Niall leads IP and technology strategy and is cofounder of Carlsmed. He is a spine industry veteran, with previous technology leadership roles at Alphatec Spine, Ellipse Technologies, NuVasive, and J&J DePuy Synthes Spine. Niall earned a J.D. from Suffolk University and an M.S. and B.S. degree in Biomedical Engineering from Case Western Reserve University.

Niall is also a medical device executive and intellectual property attorney with over twenty years of proven experience within varied corporate environments. He is an innovative and motivated individual with the capacity to manage complex programs to drive successful commercial launches. He is also an accountable professional with extensive development, IP, market, customer, and regulatory knowledge.

Mike Cordonnier

CEO & Co-Founder, Carlsmed

CEO & Co-Founder, Carlsmed

Mike is a seasoned MedTech operator, entrepreneur, and cofounder of Carlsmed. He was named as an EY Entrepreneur of the Year and to the SD500 as one of the most influential people in San Diego. Mike has operating experience at private and public companies, including NuVasive Specialized Orthopedics, Zimmer Biomet, Orchid Orthopedics, X-Spine Systems, and YSI. He is active in the entrepreneur community and servers as an advisor to San Diego based non-profits EvoNexus and SD Connect. Mike has a B.S. in Mechanical Engineering from the University of Dayton.

John DeNuzzio Ph.D.

Principal, DeNuzzio MedTech Consulting

Principal, DeNuzzio MedTech Consulting; former Senior Director, R&D, Becton Dickinson and Company (BD)

John DeNuzzio, is a Senior Director at Becton Dickinson, a global medical technology company.   He has held technical leadership positions in diabetes, infectious disease diagnostics, genomics, and infusion systems.   As a hands-on leader with over twenty-five years in the pharmaceutics and medical devices, John has built and led global R&D teams to take a customer-centric, systems-level approach to product development.  In addition, he has engaged third-party developers and worked closely with startups throughout his career.

His experience has centered on integrating diagnostics and therapeutics into wear devices, consumables, and lab-based systems.   He has successfully ushered products from concept through development, registration and launch with applications ranging from transdermal drug delivery, glucose monitoring, molecular diagnostics, and genomics.

John received BSE and Ph.D. degrees from the University of Pennsylvania in Bioengineering and Materials Science respectively.  Away from work, John enjoys traveling with family and attempting to play tennis and golf.

Rob Douglas

Advisor, ResMed Inc.

Advisor, ResMed Inc.

Rob Douglas, former President and Chief Operating Officer of ResMed Inc., in San Diego, California has over 25 years experience in operations and marketing for high-tech medical device and E-commerce solution sector leaders. ResMed Inc. is a global medical device company in the treatment of Sleep Disorder Breathing listed on the NYSE and the Australian Stock Exchange, with a market cap of ≈ U.S. $10B. Earlier, he was Chief Operating Officer for Asia Pacific & Global Supply Chain leading Asia Pacific sales and sales operations in Japan, Australia, China, India, Middle East, North Africa and ASEAN countries. Mr. Douglas joined ResMed Inc. as Vice President of Corporate Marketing becoming Vice President of Operations and Chief Operating Officer Sydney.

Previously, he was General Manager of Strategy and New Business and a member of the Executive Management Team at Keycorp Ltd., an electronic commerce company developing and marketing a range of products for secure electronic financial transactions, based in Sydney, Australia. Mr. Douglas began his career with Telectronics Pty. Ltd. an Australian medical electronics company that designed, manufactured, and globally marketed implantable cardiac pacemakers and implantable defibrillators based in Sydney.

Formerly, Mr. Douglas was a member of the Board of Directors of Continence Control Systems International and its predecessor company Colocare Ltd. Currently, he serves as Vice Chairman on the Board of Directors of EvoNexus. He also serves on the Board of Directors of the San Diego Regional Economic Development Corporation and is a member of its Executive Committee. He is a past Director of the Australian Science Media Center and former member of the Business Council of Australia.

Mr. Douglas earned an MBA from Macquarie University, and holds a Bachelor’s degree in Electrical Engineering with first-class honors and a Bachelor of Science in Computer Sciences from the University of New South Wales in Sydney.

Dr. Rakhi Garg

Product Management - Sleep & Respiratory Care, Philips Healthcare

Product Management - Sleep & Respiratory Care, Philips Healthcare

Rakhi Garg has 10+ years of experience in healthcare/medical technologies industry. She is driven by a vision to provide world-class healthcare services to patients at affordable costs. In her current role at Philips Healthcare, she is leading Trilogy ventilation platform for Hospital Respiratory Care. Prior to joining Philips, Rakhi held various product management roles at Becton Dickinson and GE Healthcare. She has also worked for a digital health startup, Sense4Baby, which was acquired by Airstrip; and a venture fund investing in medical devices and healthcare technologies. Rakhi is a physician from India and earned an MBA from the Rady School of Management at UC San Diego.

Jason Halac

Senior Director, Dexcom Ventures

Senior Director, Dexcom Ventures

Jason is the co-founder of Dexcom Ventures where he leads technology scouting and strategic pipeline development.  He is a seasoned innovator in the medical device field and a key contributor in Dexcom product development over the past decade.

Committed to Dexcom’s mission of ”Empowering people to take control of diabetes" he has advanced the simplicity, reliability, and comfort of Dexcom’s continuous glucose monitoring systems.  Jason has been a prolific inventor and is named on well over 100 worldwide patents and patent applications.

With Dexcom Ventures, Jason is chartered with building a portfolio as value-added strategic investors by leveraging access to Dexcom’s unique industry expertise and technology leadership.

Prior to Dexcom, Jason held a variety of engineering and leadership roles as a consultant and with Black and Decker.  He holds a B.S. in mechanical engineering from San Diego State University.

Michael J. Hennessy, M.D.

Independent Medical Practice Professional

Orthopedic Surgeon, Independent Medical Practice Professional

Michael J. Hennessy, M.D. is an orthopedic surgeon in San Diego. His professional training started with a surgical internship at Harvard Surgical Service Boston City Hospital in 1970. From there he completed his general surgery residency at the same hospital, and then completed his orthopedic surgery residency at Tufts University School of Medicine. He has licensure in the Commonwealth of Massachusetts, the state of Minnesota, the state of California, and, most recently, the state of Montana. He has been a part of 12 professional associations from 1979 to 1996. In California, Dr. Hennessy held roles at Mercy Hospital and Medical Center (1979-1996), Donald N. Sharp Memorial Hospital (1979-1996), Children’s Hospital and Health Center (1979-1996), and the University of California at San Diego (1980-1996). In Montana, he held roles at Benefis Healthcare (1996-2009) and Great Falls Clinic Medical Center (2005-2009). Dr. Hennessy served in the Naval Regional Medical Center in the Department of Orthopedic Surgery (1977-1978).

He has also been published in 26 professional reports throughout the years. Dr. Hennessy received his Bachelor of Science at Saint John’s University in 1966. He also received a Bachelor of Science from University of Minnesota in 1968. Then, Dr. Hennessy received his Doctor of Medicine from the University of Minnesota Medical School in 1970.

In his free time, Dr. Hennessy enjoys aviation and has a commercial license with instrument and multiengine ratings. He participates in aerobatic competitions, and enjoys woodworking, photography, and mountain climbing.

Dr. Michael Hill

Global Head, Science, Technology, and Innovation, Science Innovations, LLC

Global Head, Science, Technology, and Innovation, Science Innovations, LLC; Adjunct Associate Professor, Case Western Reserve University, School of Engineering and Weatherhead School of Management

Dr. Michael Hill is a global-minded, skilled entrepreneur and authentic leader creating meaningful, patient-inspired, medical device technology innovations from idea/discovery to commercial scale. He has deep domain knowledge of science and technology and experience with research, product development and clinical research/regulatory. He is adept in successfully leading large global, diverse organizations and high performing teams. He has a thorough understanding of the fundamentals related to global healthcare systems to deliver impactful transformative innovations. He is curious, passionate andperseveres toward creating the future.

He joined Medtronic in July 1992 as a Scientist in the Cardiac Rhythm Management division of Medtronic in Minneapolis, MN, working on arrhythmia prevention research. In 1998, Dr. Hill became a Senior Scientist and Technical Fellow in the Heart Failure division of Medtronic and led the research efforts on the novel therapy of cardiac resynchronization therapy. In 2001 he became a Bakken Fellow and Principle Clinical Program manager leading the effort on ambulatory hemodynamic monitoring and became Director of Clinical, Heart Failure New Therapies in 2003. In 2004, Dr. Hill became the Director of Clinical Research at the Bakken Research Center in the Netherlands responsible for Cardiac Rhythm Disease Management research, clinical outcome trials and health economic outcomes in Europe, Middle East and Africa. He returned to Minneapolis in 2007 as Medtronic’s Senior Director of Programs in New Therapies and Diagnostics, CRDM where he had program management responsibilities for novel therapy and diagnostic opportunities in chronic cardiac diseases. In 2012 he became Vice President of Research and Development of the Heart Failure Business Unit. In May 2016, Michael became the Vice President of Corporate Science, Technology, and Clinical Affairs, inspiring and enabling the enterprise-wide technical community to create patient-inspired, meaningful innovations. In September of 2018, Michael became the Vice President of Corporate Science & Technology and Innovation to focus on building a sustainable innovation ecosystem for Medtronic’s continued and future success. Michael retired from Medtronic in 2019 after 27 successful years of continuously bringing significant innovations to scale. He supports educational programs for science, technology, engineering and diversity & inclusion; and remains active in knowledge sharing, creating intersections, improving decision-making, and accelerating the cycle of innovation.

In 2010, Dr. Hill achieved a significant milestone obtaining his fiftieth patent in his 18 years with Medtronic; he now holds more than sixty. Dr. Hill has authored several book chapters, manuscripts, and abstracts. He is a reviewer for several medical journals and is often an invited lecturer at international healthcare and innovation conferences. He was awarded ais a global-minded, skilled entrepreneur and authentic leader creating meaningful, patient-inspired, medical device technology innovations from idea/discovery to commercial scale. He has deep domain knowledge of science and technology and experience with research, product development and clinical research/regulatory. He is adept in successfully leading large global, diverse organizations and high performing teams. He has a thorough understanding of the fundamentals related to global healthcare systems to deliver impactful transformative innovations. He is curious, passionate and perseveres toward creating the future. CRDM Star of Excellence award in 2011. In 2012, he was inducted as Fellow of the American Institute of Medical and Biological Engineering. In 2013, he was awarded the Distinguished Engineering Alumni award from Duke University. He was awarded the Medtronic Patent of Distinction Award in 2014. In 2020, he was awarded the Wallace H. Coulter Award for Healthcare Innovation, recognizing an outstanding individual who has demonstrated a lifetime commitment to and made important contributions to patient healthcare, from the Biomedical Engineering Society and Wallace H. Coulter Foundation. Dr. Hill has been a member of the American Heart Association since 1992; served on the Board of Directors of the Greater Minneapolis AHA chapter (1998 – 2005); and served as President of the Board (2003-4). He was a member of the Northland Affiliate AHA Research Committee (2001-2004) reviewing cardiovascular research grant and fellowship applications. He was awarded the AHA Research Achievement Award (Northland Affiliate) in 2002. He is member of IEEE, BMES, HRS, HFSA, and ACRP.

Dr. Hill served on the Coulter Foundation committee at Duke University (2014-2019); Steering Committee of LIRYC Institute, Bordeaux University (2014-2019) and the Technical and Leadership Advisory Committees to the American Regenerative Manufacturing Institute (2017-2019). Since 2015, he serves on the Corporate Executive Committee at Case Western Reserve University.

A native of Jackson, Tennessee, Dr. Hill received his BSE [Biomedical and Electrical Engineering] and BS [Mathematics] Degrees from Duke University, MS and PhD [Biomedical Engineering] Degrees from Case Western Reserve University, and MBA [Management] Degree from the University of St. Thomas.

Dr. Hill enjoys traveling, food and cultures, skiing and scuba diving, storytelling, and enjoying his homes in San Diego, CA; Dania Beach, FL and Barcelona, ES.

Kelly Ko, PhD

VP Innovation & Strategic Initiatives, Sharp HealthCare

Vice President, Innovation & Strategic Initiatives, Sharp HealthCare

Kelly J. Ko, PhD has a diverse work experience spanning various organizations. Starting in 2009, they worked at Cerner Corporation as a Scientist in Life Sciences Consulting, providing strategic recommendations for pharmaceutical, biotech, and payer clients. They later became a Research Client Strategist and Manager in Population Health, where they developed population health and research strategies, collaborated with cross-functional teams, and managed a team of subject matter experts.

In 2016, Dr. Ko joined West Health as the Director of Clinical Research, overseeing strategic priorities in clinical research and data science. They achieved significant accomplishments including securing funding, developing a national accreditation program, and leading a sustainability plan for a learning collaborative.

Dr. Ko also worked at the University of San Diego as an Adjunct Faculty member, teaching courses and sharing their expertise. They are currently a member of the Zahn Innovation Platform Advisory Board at San Diego State University, providing strategic guidance for the ZIP Launchpad and supporting entrepreneurial initiatives.

Most recently, Dr. Ko joined Sharp HealthCare as the Vice President of Innovation and Strategic Initiatives, where they plan, lead, and implement key innovation and strategic priorities. They focus on identifying opportunities at the intersection of technology, data, and digital health for early adoption or co-development, as well as growing strategic partnerships to diversify revenue and commercialization opportunities.

Kelly J. Ko, PhD completed their Bachelor of Arts degree in Psychology at Pepperdine University in 2003. Following that, they pursued their Master of Science degree in Developmental Psychology at the University of Utah from 2003 to 2006. Continuing their education, they earned their PhD in Psychology with a specialization in Health & Development from the University of Utah in 2008. In addition to their degrees, they also obtained a Graduate Certificate in Gerontology from the University of Utah in 2006.

Dr. Richard Kurtz

VP Corporate Business Development, Bio-Rad

Vice President, Corporate Business Development, Bio-Rad Laboratories

Richard Kurtz, Ph.D. is the Vice President of Corporate Business Development for Bio-Rad Laboratories, a life science research and clinical diagnostics company that has been serving customers worldwide since 1952. In his current role, Richard reports to the company’s Chief Strategy officer and executes corporate strategies to deliver long-term company growth, focusing on acquisitions, partnerships and technology licensing in both Life Science and Clinical Diagnostics. Richard also coordinates Bio-Rad Corporate Venture Fund investments in start-up companies with innovative products and technologies focusing on research, diagnostics and health care.

Richard has 15 years of industry experience. Previously, Richard was the Marketing Director for the Life Science Gene Expression Division, a role in which he managed long-term product-line strategies, product development and global commercialization activities for one of Bio-Rad’s largest Life Science product portfolios. He has extensive experience in strategic business planning, technology assessment, product development and commercialization. Richard received his Ph.D. in Molecular Biology from Northwestern University prior to transitioning into industry.

BIO : (NYSE) Bio-Rad Laboratories, Inc. develops, manufactures, and markets a broad range of products for the life science research and clinical diagnostics markets.

Ryan Lakin

Divisional VP, R&D, Abbott

Divisional Vice President, R&D, Abbott

Ryan Lakin is a Med Tech experienced business executive who has effectively led in business units up to $3.4B in revenue. Ryan's 25 years of global impact in Research & Development and Business Leadership has impacted patients through commercialization of technologies across diverse therapy areas including orthopedics, diabetes, neuromodulation, and pediatric care. Ryan effectively leads and delivers business results in large, publicly traded multi-national corporations (Abbott, BD, Zimmer-Biomet) while also successfully partnering with and integrating start-ups. Ryan is a results oriented global business leader with demonstrated track record in market leading innovation, developing a purpose driven culture, M&A, delivering operational efficiencies, transformative change management, and attracting, developing, and retaining top talent.

Gregg Landis, M.D.

System Chief of Vascular Surgery, Northwell Health

System Chief of Vascular Surgery, Northwell Health / Sugeon-in-Chief, Long Island Jewish Medical Center / Associate Professor of Surgery, Hofstra Northwell School of Medicine 

Gregg Landis is a Vascular Surgeon and a General Surgeon in North New Hyde Park, New York. Landis has been practicing medicine for over 28 years and is highly rated in 8 conditions. His top areas of expertise are Carotid Artery Disease, Thoracic Aortic Aneurysm, Abdominal Aortic Aneurysm (AAA), Carotid Artery Surgery, and Stent Placement. He is licensed to treat patients in New York.

Dr. Landis has extensive experience in Carotid Artery Disease or Carotid Endarterectomy, Aortic Aneurysm or Dissection, and Peripheral Vascular Disease. He graduated from UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY / NEWARK in 1995. He is affiliated with medical facilities Long Island Jewish Medical Center and North Shore University Hospital.

His clinical research consists of co-authoring 28 peer reviewed articles in the past 15 years.

Dr. Thomas Lawrie

CMO, Sharp Memorial Hospital

Chief Medical Officer, Sharp Memorial Hospital

Dr. Thomas Lawrie is a Sharp-affiliated Pulmonary disease specialist in San Diego and is the Chief Medical Officer of Sharp Memorial Hospital. He received his medical degree from University of Colorado School of Medicine and has been in practice for 20 years. As part of his partnership with Chest Medicine and Critical Care Medical Group, he provides critical care services at Sharp Memorial, Chula Vista, and Coronado Hospitals. Dr. Lawrie has received Guardian Angel recognitions from grateful patients and families throughout the course of his career.

John “Rick” LeMoine, MD

CMIO, Sharp HealthCare

Chief Medical Information Officer, Sharp HealthCare

John R. (Rick) LeMoine, MD, FACP, is the chief medical information officer for Sharp HealthCare. He is responsible for providing medical direction and physician counsel for Clinical Effectiveness and Information Systems.

A graduate of Dalhousie Medical School in Nova Scotia, Canada, Dr. LeMoine completed his fellowship program in pulmonary and critical medicine at the University of California, San Diego (UCSD). He has served on the faculty of medicine at both Dalhousie University and UCSD.

Prior to his current role at Sharp HealthCare, Dr. LeMoine held leadership roles with the Medical Society of Nova Scotia and the Canadian Medical Association. He also served as executive director for insured programs and clinical rationalization for the government of Nova Scotia.

Dr. LeMoine has had a keen interest in clinical information systems since joining Sharp HealthCare in 1982. His research interests and activities have included pulmonary and venous thromboembolism and community-acquired pneumonia.

Giovanni Magni

Mentor, Former EVP & Chief Strategy Officer, Bio-Rad

Former EVP & Chief Strategy Officer, Bio-Rad Laboratories

Giovanni is a veteran Senior Executive, C-Suite Officer, and Board Member with over 40 years of success in biotech, life sciences, pharma, medical diagnostics, and hospitals. Leveraging extensive experience in strategic leadership, commercialization, and international business, he is a valuable asset for similar-sector companies looking for acumen in R&D challenges, product development, commercialization, market research, growth, and expansion. His broad areas of expertise include product concept, design, development, launch, and management; business strategy and development; sales management; market analysis and development; competitive analysis; global marketing; international sales; and cross-functional team leadership and development.

In his executive career, Giovanni has held leadership positions at Bio-Rad Laboratories (EVP and Chief Strategy Officer. VP International Sales and Marketing); Bio-Rad Laboratories Sr (Southern Europe GM); Baxter Diagnostics; Chemetron Chimica S.p.a.; and Clinica del Lavoro. He has been responsible for the development and execution of a company's long-range global strategic plans and objectives, overseeing the analysis of trends and developments, and formulating strategy for growth and profitability of product lines and geographies. Reporting to the CEO, he has led executive collaboration to identify and prioritize strategic mergers and acquisitions, analyzing and reporting financial and operational metrics due diligence. He has led critical executive decision- making to develop the business case for initiatives and products, determining risk profiles, funding, and resource requirements for successful implementation and return on investment (ROI). He has directed European product strategy, development, and launch, including integrated marketing and sales campaigns across Italy, Spain, Portugal, and Latin America. Through his global commercialization leadership, and oversight of both internal growth and acquisitions, he spearheaded company growth from $400M to $2.2B in of all selling and marketing operations outside North America for the company's life sciences and diagnostics groups, including 6 selling regions (Europe, Japan, Asia Pacific, China, Latin America, and Emerging Markets); international operations (finance, IT, service, logistics, RA/QA, PMO, and special projects); and international HR and global talent. As EVP of an international sales organization, he was responsible for ~2500 employees and $1.4B annual sales (70% of total company sales). He is directing an international company's global venture fund, emphasizing innovation, acquisitions, and new markets.

Giovanni earned a Degree in Pharmacy from Università degli Studi di Pavia; and a Master Degree in Pharmacy from State University of Pavia. He has professional working fluency in English, Italian, and Spanish.

Zachary Myers

Partner, Wilson Sonsini Goodrich & Rosati

Partner, Wilson Sonsini Goodrich & Rosati

Zach Myers is a partner at Wilson Sonsini Goodrich & Rosati where he specializes in corporate and securities law, including mergers and acquisitions, venture capital financings, and general corporate representation. He represents private and public companies in the technology and life sciences sectors—especially biotechnology and medical device companies—in complex, high-value transactions.  He has represented a number of leading companies in venture capital financings, helping them raise millions of dollars needed to fund, grow, and expand their businesses. He has also assisted numerous clients that have gone public, listing on the New York Stock Exchange and NASDAQ markets.

Nandhu Nandhakumar

CTO, Alat, Former SVP, Office of the CTO, LG Electronics

CTO, Alat; Former SVP, Office of the CTO, LG Electronics

As the Chief Technology Officer at Alat – a transformative company backed by $100B of capital by Public Investment Fund (PIF) - Nandhu Nandhakumar leads innovation and technology strategy across our various business units comprising Smart Devices, Smart Appliances, Smart Health, Smart Buildings, Advanced Industrials, Next Gen Infrastructure, and Semiconductors.

He believes strongly in the value of cross-industry collaboration to make meaningful and impactful technology contributions. I lead partnerships with technology innovators (startups, VCs, university labs, etc.), and have founded and serve in leadership positions of various industry consortia and global technology standards development organizations.

Previously, at LG Electronics, Nandhu led initiatives in digital media, robotics, and AI. As the founding head of LG’s Technology Center of America, he established the North American Corporate Venture Capital effort, investments in startups, and collaborations with university research labs.

As member of University Faculty, Nandhu has taught graduate and undergraduate courses, and performed funded (PhD and post-doctoral) research in computer vision, AI, robotics, & video processing - funded by NASA, DARPA, NSF, USAF, etc.

Michael Nowak, PhD

Managing Partner, Nowak Ventures

Managing Partner, Nowak Ventures, LLC

Dr. Michael J. Nowak is an experienced healthcare and high-tech institutional investor in small cap public and venture-backed private companies, serial entrepreneur, and licensed investment banker. Michael has most recently served as advisor to a leading early-stage venture capital fund and their portfolio companies, two leading universities on their innovation and commercialization efforts, industry-leading corporations, and California Life Sciences Assoc. FAST program companies. Previously he was CEO and President of a Stanford University spinout and JLABs company focused on non-viral transfection technology for cell and gene therapies where he closed a significant seed round of financing from institutional and corporate VC investors. He is Managing Partner of his own consulting and advisory firm and is Managing Director at BJC Capital, an independent boutique investment bank.

In the past Michael was a Managing Director and Head of Healthcare Investments for Yorkville Advisors, $B+ AUM multinational hedge fund. Before that he led investments and served on numerous Boards of Directors while a General Partner at leading $B Euro-US venture capital fund TVM Capital. He was also a corporate venture capitalist and business development executive at Xerox PARC and Xerox Venture Labs in Palo Alto, where he was CEO of two spinouts. Furthermore, he was a strategic management consultant and Vice President at McKinsey & Co. in an emerging technology practice, and a Program Manager at the Advanced Technology Program, National Institute of Standards and Technology, US Department of Commerce. At NIST he managed two $100M+ investment programs in software and digital media technology.

Dr. Nowak earned an MBA from the Wharton School at the University of Pennsylvania and a PhD in Physics from the University of California, Santa Barbara. He worked as a post-doctoral scientist at Bell Labs (Bellcore), Princeton University, and at the CEA research labs in Saclay and the University of Paris VI (Jussieu, now Sorbonne University), in Paris, France. He received his BA in Physics from Cornell University in Ithaca, NY, where he was a College Scholar.

Carlos Nunez, M.D.

CMO, ResMed

Chief Medical Officer, ResMed

Carlos M. Nunez, M.D., was appointed ResMed’s chief medical officer in January 2017. Prior to joining ResMed, he was senior vice president of Medical Affairs at Becton, Dickinson and Company, leading the Office of Science, Medicine and Technology for its largest division. Before that, he was chief medical officer at CareFusion, where he built and led a global team that provided company-wide medical oversight.

From 2000 to 2011, Carlos was chief physician executive at Picis, Inc., an industry-leading medical informatics company that became part of the Optum division of UnitedHealth Group. At Picis/Optum, Carlos provided medical leadership and clinical direction for corporate strategy, marketing, product development, sales, implementation and customer relations for global markets.

Before working in the medtech industry, Carlos was a practicing anesthesiologist, intensivist and hospitalist; director of critical care research, informatics and analytics; and the Duke University educational affiliation at Carolinas Medical Center NorthEast.

Carlos received his medical doctorate from the University of Miami School of Medicine, where he also completed his postgraduate training in anesthesiology, critical care medicine and clinical research.

Mike Perry

Executive Chairman, Avive Solutions

Executive Chairman, Avive Solutions; Former CEO, CardioDynamics

Michael Perry is the Executive Chairman of Revive Solutions, a leading developer of a next generation Automated External Defibrillator. Mr. Perry has over 30 years of experience serving as CEO, founder, and senior executive in private and public healthcare technology companies. Those companies have achieved three consecutive successful exits, which have generated over $1 Billion in shareholder value. Mike served as the Vice President of Operations and Research and Development at Pyxis Corporation, where he was a part of the executive team that successfully acquired and integrated three businesses into Pyxis and in 1996, sold to Cardinal Health, Inc. for over $900 Million. Following his success at Pyxis, he became the CEO of CardioDynamics, an innovative medical device company in the cardiology market was that sold to Sonosite in 2009. Most recently, he was the CEO and co-founder of CRISI Medical Systems, where he was led the company from the infancy stages through FDA approval, and sold the business to Becton Dickinson (BD) in 2015. Mike received his MBA from Harvard Business School and a BS in Mechanical Engineering from General Motors Institute (now Kettering University).

Malcolm Pond, MD

Licensed Cardiologist

Licensed Cardiologist (Retired)

Malcolm S. Pond, MD, FACC graduated from Yale University and Johns Hopkins School of Medicine, and received his medical degree in 1973. He completed his residency training and cardiology fellowship at Johns Hopkins in 1978. He is board certified in internal medicine and cardiovascular diseases, and is a Fellow of the American College of Cardiology.

Dr. Pond has retired.

Dr. Karthik Ranganthan

WW VP, Alaris Business Leader, BD

WW VP, Alaris Business Leader, Becton Dickinson

Karthik leads global ~$1B Alaris infusion business, including capital equipment, interoperability, and analytics offerings. During his 14 years at Becton Dickinson, Karthik has held many positions ranging from Manager of Advanced Concept Development all the way to Vice President. He is an experienced leader of large global healthcare businesses. Karthik is comfortable with conceptualizing, launching, and scaling “new to the world” innovation, as well as managing large and mature businesses. Before working at BD, Karthik held the position of Research Scientist at PocketSonics, Inc. He was the first full-time employee of the company, and he helped lead R&D and played a key role in designing and building PocketSonics’s device. Karthik also co-invented a patent on novel ultrasound signal processing during this time.

Karthik received his MBA in General Management from Harvard’s Business School. He also holds a PhD from the University of Virginia in Biomedical Engineering. It was here that he performed his independent dissertation research on ultrasound imaging systems.

Hemanth Reddy

CSO, ResMed Inc.

Chief Strategy Officer, ResMed

Hemanth Reddy was appointed ResMed’s chief strategy officer in September 2013, responsible for the company’s global corporate strategy and corporate development functions.

Prior to joining ResMed, Hemanth was a strategy consultant for 14 years, advising on a range of issues including corporate strategy, business unit strategy, portfolio strategy, and inorganic growth strategy across consumer products, high tech, biotech and other industries. He was most recently a principal with Monitor Deloitte, Deloitte Consulting’s Strategy practice, co-leading its San Francisco office. Prior to Deloitte, he was a partner with Monitor Group where he co-led corporate finance activities in North America and shared leadership responsibility for Monitor’s Mergers & Acquisitions advisory practice. Before Monitor Group, he was an investment banker with Donaldson, Lufkin & Jenrette (DLJ) in New York, where he advised clients in structuring and executing debt and equity offerings, as well as private equity transactions.

Hemanth holds a Master of Business Administration in Finance, Strategy and Marketing from Northwestern University’s Kellogg School of Management and a bachelor’s in computer science from Cornell University’s College of Engineering.

Howard Robin, MD

President & CEO, LJ Pathology Consultants, Inc.

President & CEO, LJ Pathology Consultants, Inc.

I help biotechnology companies commercialize research assays as laboratory developed tests (LDTs) through the CLIA approval process. As a member of the College of American Pathologists and an inspector for the CAP I'm well versed in the preparation steps required for CAP accreditation.

Special interests in Anatomic and Clinical Pathology: Molecular pathology, immunopathology, forensic pathology, liver pathology, kidney pathology, blood banking, breast cancer diagnostics.

Dereck Tatman, PhD, MBA

Founder, President, & CEO, Intrigue Health

Founder, President, & CEO, Intrigue Health

Dereck Tatman brings over 25 years of industry experience to his role as founder of Intrigue Health, a stealth startup. Dereck has extensive experience in new product and franchise strategy, laboratory operations and corporate infrastructure, international sales, IP licensing, complex dispute resolution as well as strategic corporate partnerships and mergers and acquisitions.

Prior to his role at his startup, Dereck served as CEO of Global Genome Center, President and COO of AristaMD, Sr Vice President at COI Pharmaceuticals and in various roles Sequenom, Inc (acquired by LabCorp), including Senior Vice President, Business Development and Operations, where he was responsible for laboratory operations and IT, international sales and domestic managed care relationships. In these roles, he led efforts to establish noninvasive prenatal testing as a new testing standard within the company and markets around the world, including providing access to testing in nearly 90 countries.

Dereck received his MBA from the Krannert School of Management at Purdue University. He received his Ph.D. in chemistry and biochemistry from Arizona State University, where he studied photodynamic therapy, and his B.A. in chemistry from Wabash College.

Dereck enjoys supporting his two boys with innovative delish meals, and then burning off those calories with long runs.

Pieter van Rooyen

CEO, President, & Founder, Pleno

CEO, President, & Founder, Pleno; Fmr. CEO, Edico Genome

Pieter is a serial entrepreneur with a proven executive management track record and over 20 years of experience inventing and successfully commercializing breakthrough technologies. He’s held multiple senior management positions including the CEO and co-founder of three high tech, venture back start-ups across a broad range of industries including semiconductors, wireless, healthcare, life sciences, image processing and retail automation. Pieter’s passion for bringing innovative technologies to market led to raising over $100MM in equity financing and $550MM in M&A transactions.

Initially launching his career as an academic in the field of electrical engineering, he made a successful transition to the world of entrepreneurialism. Over the last 18 years, Pieter impacted multiple markets, building a portfolio of over 150 issued patents, 50 technical papers, and authoring two academic books. Most recently, he was the co-founder, President and CEO of Edico Genome, a leading secondary analysis solution provider for Next-Generation DNA Sequencing and a recent acquisition by Illumina in May 2018.

Pieter has a talent for inventing complex and technical products, building synergistic leadership teams, and creating significant shareholder value across a broad range of industries. Hi passion for taking numerous ideas from concept to a commercialized product has made a significant impact on the field of technology.

His areas of expertise include: Technology Commercialization, Product Development, High Tech Inventions, Strategic Planning, Business Development, Revenue and Sales Growth, Executive Team Leadership, Equity Financing, Start-ups, Genomics, Wireless Communications, Mergers and Acquistions, Patent Portfolios.

Dr. Josh Windmiller

Head of New Analytes & Sensing Platforms, Dexcom

Head of New Analytes and Sensing Platforms, Dexcom

Dr. Joshua Windmiller is the Head of New Analytes and Sensing Platforms at Dexcom, where he is currently leading a brilliant team of cross-functional innovators thinking about the future of wearable sensing. Prior to this, Dr. Windmiller was the Chief Technology Officer and Co-Founder of Biolinq, Inc. He is an internationally-recognized expert in printed biosensor technology. His Ph.D. research, funded by a Powell Foundation fellowship, focused on the development of printed biosensors, bioelectronics, and biofuel cells. He has published over 50 manuscripts in peer-reviewed journals and conference proceedings and has eleven US patents issued or pending. Dr. Windmiller, a Gordon Fellow, NIH SHIFT awardee, and two-time NIH Lab-to-Marketplace awardee is the recipient of the Printed Electronics USA 2010 Academic R&D award for his developments in textile-based printed bioelectronics.

He completed a postdoctoral fellowship in the Laboratory for NanoBioElectronics at UCSD in 2013, where he was supported by the von Liebig Center for Entrepreneurism and led a commercialization grant sponsored by the DOE. For his successful product development activities leading to the commercialization of novel printed bioelectronic paradigms, he received the Printed Electronics USA 2014 Product Development award. He currently serves as the CTO of Biolinq, a startup that he co-founded devoted to the development of the novel biosensing modalities he has invented for application in the personal wellness and healthcare domains.

Rory Moore

Rory Moore

EvoNexus CEO & Co-Founder, Founder, Peregrine Semiconductor Corp. & Silicon Wave, Inc.
Rich Stewart

Rich Stewart

EvoNexus Executive Advisor & 5G Portfolio Director, Former Senior Director, Qualcomm
John Major

John Major

EvoNexus Chairman Emeritus, Former Chairman, Broadcom
Ron Melanson

Ron Melanson

EvoNexus Silicon Valley Chief Engineer & Operations, Former VP Hardware Engineering, Sun Microsystems & Oracle
Behrooz Abdi

Behrooz Abdi

Strategic Advisor, TDK InvenSense
Behnam Analui

Behnam Analui

Co-Founder, Abtum
Ziad Asghar

Ziad Asghar

SVP, Product Management - Snapdragon Technologies & Roadmap, Qualcomm
Charles Bergan

Charles Bergan

VP Engineering, Qualcomm Wireless Research and Development
Dr. Ivo Bolsens

Dr. Ivo Bolsens

Mentor, Former SVP, AMD
Mark Bowles

Mark Bowles

Founder, ecoATM/ Truvian
Kurt Busch

Kurt Busch

CEO, Syntiant
Girish Chandran

Girish Chandran

Corporate CTO, Viasat
Dr. Tallis Chang

Dr. Tallis Chang

Co-Founder & COO, Obsidian Sensors
Frank Creede

Frank Creede

Mentor, Former CTO, Anterix
Mouna Elkhatib

Mouna Elkhatib

CEO/CTO/Co-Founder, AONDevices
Dana Escobar

Dana Escobar

CLO & GM, Semiconductor, Adeia
Adam Gould

Adam Gould

CEO, Lynq Technologies
Steve Hart

Steve Hart

Co-Founder, EVP, CTO, Viasat
Patrick Henry

Patrick Henry

President & CEO, GroGuru
Dr. John Hong

Dr. John Hong

CEO, Obsidian Sensors
George Imthurn

George Imthurn

Principal Engineer, Qualcomm
Dr. Seung Kang

Dr. Seung Kang